
Herbs & Botanicals · Herbs · Succulent leaf gel, latex and extracts, with low-certainty or weaker evidence for every use
Aloe Vera
Aloe vera (L.) Burm.f. (also called Aloe barbadensis Mill.) · also called Aloe vera, aloe, Barbados aloe, West Indian aloe, burn plant, acíbar and babosa (Spanish and Portuguese), aloès vrai (French), echte Aloe (German), ghritkumari (Hindi), 芦荟 lúhuì (Chinese)
Aloe vera is a fleshy succulent. Its leaf gives three very different materials: the clear inner-leaf gel used on skin and sold as juice, the bitter yellow latex under the leaf skin, which contains aloin and is a strong laxative, and whole-leaf extracts, which can contain both. This profile keeps them apart. No use reaches better than low certainty. Minor burns, acne, oral lichen planus, oral submucous fibrosis, mouth sores from cancer treatment, gum inflammation, blood sugar, weight, irritable bowel syndrome, ulcerative colitis and the latex as a laxative are low; wound healing beyond burns, radiation bowel irritation, gum pockets, acid reflux and vitamin levels are very low; psoriasis and radiotherapy skin reactions are mixed; blood fats are insufficient; and sunburn is against. Safety: aloe latex and aloin cause cramps, diarrhoea and potassium loss and must be avoided in pregnancy, breastfeeding and under age 12; a non-decolorized whole-leaf extract caused bowel cancers in rats and is rated possibly carcinogenic to humans; oral aloe has been linked to liver injury; and aloe can interact with heart, water and blood-sugar medicines.
General information, not medical advice. Last substantive update · Not medically reviewed. A named clinician has not signed off on this page. How this page is made
About Aloe Vera
Aloe vera is a succulent whose leaf gives three different materials: the clear inner-leaf gel used on skin and in drinks, the bitter yellow latex under the leaf skin, which is a strong laxative because of aloin, and whole-leaf extracts, which may or may not have the latex filtered out. Evidence is low or weaker for every use: minor burns (about 4 days faster healing in pooled trials, with conflicting reviews), blood sugar, irritable bowel syndrome and several mouth conditions are low; psoriasis and radiotherapy skin reactions are mixed; sunburn is against. Safety matters more than benefit here. Aloe latex causes cramps, diarrhoea and potassium loss and is not for pregnancy, breastfeeding or children under 12; a non-decolorized whole-leaf extract caused bowel cancers in rats; oral aloe has been linked to liver injury; and the gel can irritate or cause allergy. For amounts, ask a doctor or pharmacist.
What it is
Aloe vera (Aloe vera (L.) Burm.f., also called Aloe barbadensis Mill.) is a fleshy succulent in the asphodel family (Asphodelaceae) with thick, toothed leaves in a rosette. GBIF and NCBI both list it as an accepted species with Aloe barbadensis as a synonym. Many other aloes exist, among them Aloe ferox (cape aloe) and Aloe arborescens, and some studies and the EU laxative monograph cover those species, so results should not be moved between them.
The leaf holds three materials. The clear gel in the centre is mostly water and carbohydrates and is used on skin and in drinks. The latex, a bitter yellow juice under the leaf skin, holds aloin and other anthraquinones and is the laxative material. Whole-leaf extracts can hold both. Filtered, 'decolorized' extracts have the anthraquinones removed; 'non-decolorized' ones do not. This page keeps them apart because most of the safety problems belong to the latex and the non-decolorized extract.
Traditional and current uses
Aloe is a traditional remedy in many places. A book chapter summarises use in India for constipation, colic, skin diseases and infections, in Trinidad and Tobago for high blood pressure, among Mexican Americans for type 2 diabetes, and in Chinese medicine for fungal disease; it says few of these claims have had robust clinical testing. Claims of use in ancient Egypt and Greece are repeated widely but were not verified here.
The EU herbal committee accepts aloe dried leaf juice, the latex-type material, only for short-term use in occasional constipation. Today people mainly put the gel on burns and skin, use mouthwashes and drinks, and take oral products for blood sugar and the gut. NCCIH says topical gel may speed burn healing, and that research on other uses is small.
What is in it and how it works
The gel carries carbohydrates such as acemannan and glucomannan, allantoin and salicylic acid (LactMed). In cell and animal studies acemannan stimulated immune cells, raised growth factors in gum cells and improved healing of rat palate wounds, but a 2021 review calls the results contradictory, and nothing shows that these effects explain any human result.
The latex carries aloin. It reaches the large bowel unabsorbed, where gut bacteria turn it into aloe-emodin anthrone, which speeds the bowel and pulls water and salts into it. A bowel movement follows after about 6 to 12 hours. Aloe-emodin is poorly absorbed and quickly turned into rhein in rats. Aloin content varies hugely with processing: below 0.1 mg per litre in filtered gel products and above 10 mg per litre in unfiltered ones in one survey of Greek products.
What the research shows
Skin and mouth uses are the most studied. Minor burns (low) and acne added to tretinoin (low) look best, with other uses mixed or weaker: psoriasis trials disagree; radiotherapy skin reactions were not prevented in the largest trials; oral lichen planus, oral submucous fibrosis, mouth sores from cancer treatment and gum inflammation are low; wounds beyond burns, radiation bowel irritation and gum pockets are very low; and sunburn is against.
Taken by mouth, aloe vera lowered blood sugar and HbA1c in pooled trials (low, because results are uneven and one review shows publication bias), reduced irritable bowel symptoms modestly (low), raised response rates in one ulcerative colitis trial (low), and reduced weight in one trial (low). Acid reflux and vitamin levels are very low, and blood fats are insufficient. Results are for the named product and cannot be assumed for another. Almost no trial says whether its aloe was gel, whole-leaf extract or contained latex.
23 49 33 13 19 64 9 24 34 26 51 41 11 54 46 53 48 21 3 44 1 12 2 15 55 42 50 16 4 10 5 22 59 39 31 40 14 57
At a glance
Traditional uses history, not proof
- Traditional medicine in India, the Caribbean, Mexico and China: a modern book chapter lists constipation, colic, skin diseases, worm infestation, infections, high blood pressure, diabetes and fungal disease (summary only).
- European herbal medicine: the EU accepts aloe dried leaf juice (the latex-type material) only for short-term occasional constipation, not the gel.
- Home use: gel rubbed on burns and sunburn, and juice drunk for the gut; the research here tests these ideas.
Studied for research
- Minor burns, acne, oral lichen planus, oral submucous fibrosis, oral mucositis, gum inflammation, blood sugar, body weight, irritable bowel syndrome, ulcerative colitis and the latex as a laxative, low
- Wound healing beyond burns, radiation bowel irritation, gum pockets, acid reflux and vitamin levels, very low
- Psoriasis and radiotherapy skin reactions, mixed; blood fats, insufficient
- Sunburn, against
Main compounds
- Aloin (barbaloin), an anthraquinone-type compound in the latex that gut bacteria turn into a laxative form
- Aloe-emodin, a related compound formed in the gut and also studied alone
- Acemannan and other gel carbohydrates, studied in cells and animals for immune and wound-healing effects
Common forms
- Inner-leaf gel, on the skin or in the mouth, and as juice
- Latex or dried leaf juice, sold as a laxative
- Whole-leaf extract, decolorized (anthraquinones filtered out) or non-decolorized
- Capsules and syrups of varied makeup
Research links: US National Center for Complementary and Integrative Health: Aloe Vera · EU herbal monograph on aloe dried leaf juice (European Medicines Agency) · US National Toxicology Program study of non-decolorized aloe whole-leaf extract in rats and mice (abstract) · Aloe vera for burn injuries: meta-analysis of randomized trials (abstract) · LiverTox: Aloe Vera (abstract) · Research Library · Genes & Biomarkers Library
The plant and its history
- Accepted scientific name
- Aloe vera (L.) Burm.f.
- Naming authority
- (L.) Burm.f., published in Fl. Indica: 83 (1768) (GBIF, usageKey 2777724, status ACCEPTED). The basionym is Aloe perfoliata var. vera L. (1753). NCBI Taxonomy lists the species as Aloe vera (taxid 34199) with Aloe barbadensis and Aloe perfoliata var. vera as synonyms.
- Synonyms
- Aloe barbadensis Mill.; Aloe perfoliata var. vera L.; Aloe perfoliata var. barbadensis (Mill.) Aiton; Aloe vulgaris Lam.; Aloe barbadensis var. chinensis Haw.; Aloe vera var. chinensis (Haw.) A.Berger; Aloe vera var. littoralis J.Koenig; Aloe chinensis Steud. ex Baker; Aloe elongata Murray; Aloe flava Pers.; Aloe indica Royle; Aloe rubescens DC.
- Common names
- Aloe vera (English); Aloe (English); Barbados aloe (English); West Indian aloe (English); Curaçao aloe (English); Indian aloe (English); Burn plant (English); Acíbar, aloe, aloja (Spanish); Babosa, babosa-medicinal, aloé-dos-barbados (Portuguese); Aloès vrai, aloès des Barbades, aloès vulgaire (French); Echte Aloe (German); Äkta aloe (Swedish); Ghritkumari, Gwarpatha (Hindi (as given in a review)); Lúhuì (芦荟) (Chinese (as given in a review))
- Botanical family
- Asphodelaceae (the asphodel family, order Asparagales; subfamily Asphodeloideae per NCBI). Older papers file aloe under the lily family (Liliaceae), and some under Aloaceae or Xanthorrhoeaceae; Dat 2012 and Jangra 2022 use Liliaceae and Suksomboon 2016 uses Xanthorrhoeaceae. GBIF and NCBI both give Asphodelaceae.
- Classification
- Plantae > Tracheophyta > Liliopsida (monocots) > Asparagales > Asphodelaceae > Aloe > Aloe vera
- Native range
- Not verified from a flora in this work. The species is grown and naturalised in warm regions worldwide, and where it is truly wild is uncertain; sources read give no range.
- Habitat
- Not verified from a flora. A fleshy, drought-tolerant succulent grown in warm, dry climates and as a pot plant. General knowledge only.
- What the plant looks like
- Roots: Fibrous roots. General description, not checked against a flora.; Stems: Very short stem, so leaves form a ground-level rosette. General description.; Leaves: Thick, fleshy, grey-green, lance-shaped leaves with toothed margins. Under the skin is a yellow bitter juice (latex), and in the centre is the clear gel (LactMed and EMA describe the two separate materials). Leaf descriptions are general, not checked against a flora.; Flowers: A tall spike of yellow tubular flowers. General description.; Fruit: A capsule. General description.
- Cultivation
- Grown commercially for gel and leaf extracts. How leaves are cut and processed changes the aloin content of the final product (p32643805). Cultivation details were not taken from a primary source.
- Harvest and processing
- The leaf has three materials that products draw from: the inner gel, the latex under the skin, and the whole leaf. 'Decolorized' whole-leaf extracts are filtered to remove anthraquinones; 'non-decolorized' ones are not (NCCIH, OEHHA). Filtering or industrial processing brought aloin in leaf gel products below 0.1 mg/L while unfiltered samples had more than 10 mg/L (Kaparakou 2021).
- Look-alikes and adulterants
- Name: Cape aloe (Aloe ferox Mill.); Note: A different accepted species (GBIF key 2777789). The EU laxative monograph covers dried juice from A. barbadensis and mainly A. ferox together, so laxative-juice rules cannot be read as gel rules (s-ema-hmpc-aloe-2016).; Name: Tree aloe or candelabra aloe (Aloe arborescens Mill.); Note: A different accepted species (GBIF key 2777537). LactMed mentions an A. arborescens leaf gel poultice on nipples in one study, so some studies are not about A. vera (p30000889).; Name: Soap aloe or spotted aloe (Aloe maculata All.); Note: A different accepted species (GBIF key 2777430) that is easily confused by name with the old synonym Aloe maculata Forssk. of A. vera in GBIF's record.; Name: Other Aloe species and succulents; Note: The genus has more than 400 species, and only a few (A. vera, A. ferox, A. arborescens) are traded widely (Radha 2015, p26151005). Do not assume results carry over to other aloes, and do not use a garden plant you cannot identify.
Traditional use and history history, not clinical proof
| Tradition or era | Documented use | Source |
|---|---|---|
| Traditional medicine (India, Caribbean, Mexico, China) as summarised in a modern book chapter | Benzie's chapter says aloe is used in traditional Indian medicine for constipation, colic, skin diseases, worm infestation and infections; in Trinidad and Tobago for hypertension; among Mexican Americans for type 2 diabetes; and in Chinese medicine for fungal diseases, and that few claims have had robust clinical investigation. Only the chapter summary was read. | p22593933 |
| Ancient Egypt and Greece (commonly repeated) | Aloe is widely said to have been used in ancient Egypt and Greece. NOT verified: no primary or regulatory source read for this work states it, so it is not relied on here. | none |
| Laxative use and EU regulation, 2006 to 2016 | The EU herbal committee first adopted its monograph on aloe dried leaf juice on 7 September 2006 and adopted a systematic revision on 22 November 2016. It allows the juice only for short-term use in occasional constipation. | s-ema-hmpc-aloe-2016 |
| US FDA, 2002 | NCCIH reports that FDA required aloe latex to be removed from over-the-counter laxatives in 2002 because of a lack of safety data. NOT verified from the original rule. | s-nccih-aloe-vera |
| Modern cancer-safety assessments, 2013 to 2016 | The US National Toxicology Program reported in 2013 that non-decolorized whole-leaf extract caused large-intestine cancers in rats, and IARC classified that extract as possibly carcinogenic to humans (Group 2B) in volume 108 (2016, per OEHHA); the classification is known here from NCCIH and a review, not from the monograph. | p24042237 |
Traditional use shows how a plant was used. It does not show that a supplement works or is safe today.
What is inside, and how it may work
What the plant contains and how those compounds act in cells and animals. Laboratory and animal mechanisms are not proven effects in people.
Main compounds
| Compound | Family | Where it is concentrated | Activity studied | Level of evidence |
|---|---|---|---|---|
| Aloin A (barbaloin) and aloin B (isobarbaloin) PubChem 12305761 | anthrone C-glycoside (anthraquinone family) | Leaf latex (the bitter yellow juice under the leaf skin) In Greek leaf gel products, below 0.1 mg/L in industrially processed or lab-filtered samples and above 10 mg/L in unprocessed, unfiltered samples (p32643805). PubChem CIDs: aloin A 12305761, aloin B 14989, unspecified aloin 9866696. | The main laxative compound of aloe latex. It reaches the large bowel and is converted by gut bacteria to aloe-emodin anthrone, which stimulates the bowel (EMA). Its content is the key difference between gel, latex and decolorized products. 59 27 25 | Authoritative guidance |
| Aloe-emodin PubChem 10207 | anthraquinone | Latex; also formed in the gut from aloin | Formed by gut bacteria from aloin. In rats about 20 to 30 percent of an oral dose appeared in urine and it was turned quickly into rhein. A review reports poor intestinal absorption, a short half-life and low bioavailability, and hepatotoxicity and nephrotoxicity as main toxicity concerns. EMA cites genotoxic risk for related anthranoids. 30 17 59 25 | Animal research |
| Aloe-emodin anthrone (aloe-emodin-9-anthrone) PubChem 122840 | anthrone | Formed in the colon from aloin | The main active laxative form produced by gut bacteria from aloin. How much is absorbed is not known (EMA). 59 | Authoritative guidance |
| Emodin PubChem 3220 | anthraquinone | Dried leaf juice (described by EMA as a major constituent) | In mice emodin caused kidney damage and in rats it changed oestrous cycle length (EMA). Several hydroxyanthracene derivatives were genotoxic in vitro. 59 | Animal research |
| Rhein PubChem 10168 | anthraquinone | Metabolite of aloe-emodin | In rats aloe-emodin was quickly converted to rhein. After other anthranoids, rhein-type metabolites pass into breast milk in small amounts (EMA). 30 59 | Animal research |
| Acemannan PubChem 134129847 | acetylated mannan polysaccharide (a gel carbohydrate) | Inner-leaf gel | Called the major carbohydrate fraction of the gel. In mouse macrophage cells it stimulated cytokines; in human gum fibroblasts it raised IL-6 and IL-8 through TLR5 and NF-kB, and in rat palate wounds it improved healing. A 2021 review notes the literature is contradictory. 58 52 26 47 | Laboratory research |
| Glucomannan PubChem 24892726 | polysaccharide | Inner-leaf gel | LactMed lists glucomannan and acemannan among the gel's mono- and polysaccharides. No specific activity was read. 36 | Authoritative guidance |
| Allantoin PubChem 204 | small organic compound | Inner-leaf gel | Listed by LactMed among gel ingredients. No specific activity was read. 36 | Authoritative guidance |
| Salicylic acid PubChem 338 | phenolic acid | Inner-leaf gel | Listed by LactMed among gel ingredients. A case report suggested aloe may reduce prostaglandin production and platelet clumping (p15292490), which is not shown to come from this compound. 36 32 | Authoritative guidance |
Mechanisms, receptors and pathways
| Target or pathway | Gene or receptor | What was found | Level |
|---|---|---|---|
| Stimulant laxative action of anthraquinones (human pharmacology summary) | Colon motility; epithelial sodium and chloride transport | The EU monograph says hydroxyanthracene derivatives speed colonic transit and also block absorption of water and salts and make the bowel lining leakier, so more fluid and salt stay in the bowel. A bowel movement follows after about 6 to 12 hours. 59 | Authoritative guidance |
| Gut bacteria convert aloin to its active form | Bacterial enzymes (for example Eubacterium sp. strain BAR) | Aloins pass directly into the large intestine and bacterial enzymes turn them into aloe-emodin-9-anthrone. A review also says gut flora form aloe-emodin, linked to the harmful effects discussed (carcinogenicity, genotoxicity, nephrotoxicity). 59 25 | Authoritative guidance |
| Macrophage activation by acemannan | Cytokines IL-6 and TNF-alpha, nitric oxide | In the RAW 264.7 mouse cell line, acemannan raised IL-6 and TNF-alpha in a dose-dependent way, and nitric oxide, cell shape and surface markers with interferon-gamma. 58 | Laboratory research |
| TLR5 and NF-kB signalling in gum fibroblasts | TLR5; NF-kB p50/p65 | Acemannan increased IL-6 and IL-8 and p50 DNA-binding in human gingival fibroblasts; an anti-TLR5 antibody blocked it and computer modelling showed binding to TLR5. Cell and computer work only. 52 | Laboratory research |
| Wound healing signals | KGF-1, VEGF, type I collagen | Acemannan raised fibroblast proliferation and KGF-1, VEGF and type I collagen in cell culture, and 0.5% acemannan in a gel improved healing of punch wounds in the rat palate. 26 | Animal research |
| Other proposed effects of acemannan (review) | Mannose receptor; short-chain fatty acids | A 2021 review says fragments of acemannan may act on mannose receptors on immune cells, topical acemannan with chitosan may promote granulation tissue and M2 macrophage polarisation, and in the gut it slows sugar release and is fermented to short-chain fatty acids, but results are contradictory and more research is needed. 47 | Laboratory research |
| Prostaglandin and platelet effects (proposed) | Cyclooxygenase pathway | The authors of a bleeding case report proposed that compounds in aloe vera may reduce prostaglandin synthesis and so secondary platelet aggregation. This is a theory, not a measured effect. 32 | Pharmacological theory |
| Bowel overgrowth and cancer from non-decolorized whole-leaf extract | Large intestine epithelium | Two years of non-decolorized extract in drinking water caused hyperplasia in the large intestine of rats and mice and large-intestine cancers in rats. The mechanism was not given in the abstract. 8 | Animal research |
| Genotoxicity of hydroxyanthracene derivatives | DNA | Several hydroxyanthracene derivatives were mutagenic and genotoxic in several in vitro test systems, not proven in vivo (EMA). A 2023 review concluded drinkable inner-leaf and decolorized products with no more than 10 ppm aloin are not genotoxic. 59 28 | Laboratory research |
| Liver and kidney toxicity of aloe-emodin | Hepatocytes; kidney tubule cells | A review of the isolated compound reports hepatotoxicity and nephrotoxicity as its main toxicity concerns. It is not the same as whole aloe. 17 | Review of animal and lab work |
| Raised blood levels of vitamins C and B12 after aloe | Unknown | In 15 healthy adults, aloe gel and decolorized whole-leaf aloe taken with vitamins gave higher plasma vitamin C and B12 than water. The mechanism is not known. 57 | Human data |
Absorption, metabolism and elimination
- Absorption
- Aloin is not absorbed in the upper gut but passes directly to the large intestine, where bacterial enzymes make aloe-emodin-9-anthrone; how much of that is absorbed is not known. In animal experiments at least 20 to 25% of an oral dose of aloe-emodin is absorbed (EMA). Human absorption data for aloin or the gel sugars were not found in the sources read.
- Distribution
- In rats given radio-labelled aloe-emodin, only liver, kidney and intestinal tract had higher levels than plasma; ovary levels were about a third and testis about a tenth of plasma levels (p8234417). Human tissue data were not found.
- Metabolism
- Aloe-emodin is quickly oxidised to rhein and an unknown metabolite and conjugated (rats; EMA, p8234417). About 10% of plasma radioactivity was free aloe-emodin at the peak.
- Elimination
- In rats 20 to 30% of the radioactive dose appeared in urine and the rest in faeces; the terminal half-life of radioactivity in blood was about 50 hours (p8234417). Urine may turn yellow or red-brown, which is not clinically significant (EMA). After other anthranoids, rhein-type metabolites pass into breast milk in small amounts, and placental passage of rhein was low in animals (EMA).
- Bioavailability
- Poor. A review of isolated aloe-emodin reports poor intestinal absorption, short elimination half-life and low bioavailability (p31680350). EMA says its bioavailability is much lower than its absorption because it is quickly oxidised and conjugated. The gel carbohydrates (acemannan) are described in a review as fermented by gut microbes to short-chain fatty acids, but no human measurement was read. In a crossover trial of 15 healthy adults, aloe gel raised blood vitamin C and B12 (p22435613).
Isolated compounds versus whole extracts
'Aloe vera' covers several different materials. (1) Inner-leaf gel: the clear gel from the centre of the leaf, mostly water and carbohydrates such as acemannan and glucomannan (LactMed); this is what skin products, gels and most drinks use, and it carries little aloin when well prepared. (2) Latex: the bitter yellow juice just under the leaf skin, rich in aloin and other anthraquinones; it is the laxative material, regulated as a laxative in the EU and removed from US over-the-counter laxatives in 2002 (as reported by NCCIH). (3) Whole-leaf extract: made from the whole leaf; the non-decolorized form keeps the anthraquinones and caused bowel cancers in rats, while the decolorized form is filtered to remove them (NCCIH, OEHHA). (4) Isolated compounds such as aloe-emodin and acemannan, which are studied in the lab and cannot stand in for a whole product. Because processing changes aloin content from below 0.1 mg/L to above 10 mg/L (Kaparakou 2021), results and risks from one product cannot be moved to another, and a trial that does not say which material it used (many do not) can be read only as 'aloe vera of unspecified type'.
Nutritional composition
A food-nutrient table was not retrieved for this file: a USDA FoodData Central search for 'aloe vera' returned no results on 2026-10-25 (unverified; possibly a request limit). Inner-leaf gel is mostly water and carbohydrates (LactMed), is used as a skin product or drink rather than a nutritional food, and values for vitamins and minerals should not be assumed. Sources read give no per-100 g values.
2 mixed findings11 low certainty5 very low certainty1 not enough evidence1 evidence against
What was looked at
The 20 benefits and uses checked for Aloe Vera, each with how strong the evidence is. Tap one to open it.
- Minor burns (first- and second-degree): faster healingLow certainty
- Other wounds: skin-graft donor sites, post-surgery wounds and diabetic foot ulcersVery low certainty
- Plaque psoriasis: calming skin plaquesMixed findings
- Skin reactions during radiotherapy: preventionMixed findings
- Bowel irritation after pelvic radiotherapy: acute radiation proctitisVery low certainty
- Acne vulgaris: added to a tretinoin creamLow certainty
- Oral lichen planus: mouth soresLow certainty
- Oral submucous fibrosis: mouth burning and stiffnessLow certainty
- Mouth sores from cancer treatment: oral mucositisLow certainty
- Gum inflammation and dental plaque: aloe mouthwash and toothpasteLow certainty
- Gum disease (periodontitis): aloe gel placed in the gum pocketsVery low certainty
- Sunburn: prevention and treatmentEvidence against
- Blood sugar in prediabetes and type 2 diabetes: aloe vera taken by mouthLow certainty
- Body weight and fat in people with obesity and prediabetesLow certainty
- Irritable bowel syndrome (IBS): symptom reliefLow certainty
- Constipation: aloe LATEX and dried leaf juice (not the gel) as a laxativeLow certainty
- Ulcerative colitis: oral aloe vera gelLow certainty
- Acid reflux (GERD): aloe vera syrupVery low certainty
- Blood fats (cholesterol and triglycerides)Not enough evidence
- Vitamin C and B12 levels when taken with aloeVery low certainty
Lab markers tracked in the studies
Burn healing time (days)Psoriasis Area and Severity Index (PASI)Radiation skin reaction scoreMouth pain or burning (visual analogue scale)Severe oral mucositis (grade 3 and 4)Probing pocket depth and clinical attachment level (gum disease)Acne lesion scoresC-reactive protein (CRP)Fasting blood glucoseHbA1c (3-month blood sugar average)Body weight and body fat massFasting insulin and insulin resistance (HOMA-IR)IBS symptom scoreColitis activity (Simple Clinical Colitis Activity Index and histology)Plasma vitamin C and vitamin B12Triglycerides
What is Aloe Vera good for?
The main proposed uses and how strong the human evidence is for each. No use reaches moderate. 'Low' means the trials point one way but are small or uneven; 'mixed' means trials disagree; 'against' means a trial found no effect. Most results are for aloe gel; aloe latex is covered separately.
Benefits, one by one
Each card is a research question, not a promise. Tap a goal to filter. Open a card to see the studies, doses and limits.
Minor burns (first- and second-degree): faster healing
Low certaintyAloe vera inner-leaf gel put on the skin may help minor burns heal a few days sooner than other dressings. The trials are small and varied, and an older Cochrane review of wounds called the evidence too weak to rely on. Pain relief is not shown.
6 studiesTopical aloe vera gel or cream; products and strengths varied between…
Studies, doses and limits
What the trials found
A 2024 meta-analysis of randomized trials (Huang, 9 trials; 6 gave healing-time data) found aloe vera shortened healing of burns, mainly second-degree, compared with other topical treatments, with no clear difference in pain or infection. A 2022 meta-analysis (Sharma; 4 trials, 133 patients, 163 wounds) of second-degree burns also found faster healing. A 2007 review (Maenthaisong; 4 trials, 371 patients) found healing about 8.8 days shorter, but its authors said the products and measures differed too much for firm conclusions. The Cochrane review of aloe for wounds (Dat 2012; 7 trials, 347 people, high risk of bias) found that aloe vera mucilage did not heal burns faster than silver sulfadiazine, and said there was not enough good trial evidence to support aloe for acute or chronic wounds.
Results
Newer pooled analyses point to healing about 4 days sooner on average for second-degree burns. The older Cochrane review found no clear gain over silver sulfadiazine. Pain and infection were not clearly different from the comparison treatments in the 2024 analysis.
Effect sizes as reported
Healing time: mean difference -3.76 days (95% CI -5.69 to -1.84) vs other topicals (Huang 2024); -4.44 days, P = 0.004 (Sharma 2022); -8.79 days, P = 0.006 (Maenthaisong 2007). Pain: MD -0.76 points (95% CI -1.53 to 0.01). Infection: RR 1.10 (95% CI 0.34 to 3.59). Aloe vs silver sulfadiazine for burn healing: RR 1.41 (95% CI 0.70 to 2.85) (Cochrane 2012).
Why this rating
The pooled results point the same way, but they rest on a small number of small trials with differing aloe products and comparison treatments, and the older Cochrane review rated the trials as high risk of bias. The 2024 review used GRADE, but the abstract does not give its ratings.
Form and dose studied
Topical aloe vera gel or cream; products and strengths varied between trials and are often not described in the abstracts.
Who was studied
People with first- to second-degree burns, mostly small hospital or clinic trials.
Limits
Different gel products, mixed comparison treatments, small trials, only abstracts read. Results cover minor burns, not deep or large burns.
Why researchers looked
Aloe gel is one of the best-known home remedies for burns, and burns are common, so it has been tested against standard dressings and creams.
Traditional use
Aloe leaf gel has long been rubbed on burns and sunburn in many cultures. This is a traditional use; the trials below test the gel itself.
Proposed mechanism Preliminary mechanism
Lab work on aloe gel sugars (acemannan) shows they can stimulate skin-repair cells and immune cells in a dish and in rat mouth wounds. Nobody has shown that this is what speeds up burn healing in people.
A proposed mechanism does not show that the effect happens in people.
Do not treat serious burns at home. The gel itself was usually well tolerated, but contact allergy and irritation are possible (see the safety file).
Other wounds: skin-graft donor sites, post-surgery wounds and diabetic foot ulcers
Very low certaintyFor wounds other than minor burns the picture is thin and mixed. A small trial found skin-graft donor sites healed about two days sooner, two small trials in diabetic foot ulcers were positive, and the Cochrane review found trial quality too poor to say, with one trial in which aloe delayed the healing of an open surgical wound.
6 studiesTopical aloe vera gel; one trial used an aloe vera plus Plantago majo…
Studies, doses and limits
What the trials found
The Cochrane review (Dat 2012; 7 trials, 347 people) found a faster healing time after haemorrhoid surgery, no difference in pressure-ulcer healing, and one trial of surgical wounds healing from the bottom up in which aloe vera significantly delayed healing; it judged the trials to be at high risk of bias. In a double-blind trial of split-thickness skin-graft donor sites (Burusapat 2018; 12 patients, 24 sites) the aloe gel sites epithelialized in 11.5 versus 13.7 days with placebo. A 66-patient trial in diabetic foot ulcers (Irani 2024) found a greater fall in a wound score at 3 weeks, and a 40-patient trial of a gel combining aloe vera with Plantago major (Najafian 2019) reduced ulcer size but not depth. NCCIH says there is not enough reliable information for diabetic foot ulcers.
Results
Some small trials favoured aloe gel and one favoured the control. Pain at the graft site did not differ.
Effect sizes as reported
Donor-site epithelialization 11.5 +/- 1.45 vs 13.67 +/- 1.61 days (p < 0.05); pain scores not significantly different (Burusapat). Surgical wound healing by secondary intention delayed by a mean of 30 days (95% CI 7.59 to 52.41) (Dat, one trial). Combination Aloe vera/Plantago major gel: ulcer surface P = 0.039, depth P = 0.263.
Why this rating
Very small trials, mixed results, high risk of bias per Cochrane, and the diabetic foot ulcer trials give only p-values in the abstract. One trial is a combination product.
Form and dose studied
Topical aloe vera gel; one trial used an aloe vera plus Plantago major combination gel.
Who was studied
Graft donor sites, post-haemorrhoidectomy patients, pressure ulcers, surgical wounds, diabetic foot ulcers.
Limits
Tiny trials, different wound types, abstracts only. A combination product cannot show what aloe alone does.
Why researchers looked
Aloe gel is widely used on cuts and sores, so trials have tried it on surgical wounds, donor sites and ulcers.
Traditional use
Aloe leaf gel is a traditional remedy for wounds. This is a traditional use.
Proposed mechanism Animal research
In rat mouth wounds, a purified aloe sugar (acemannan) increased wound closure and raised growth factors in cultured gum cells. This is animal and lab work and may not apply to other wounds.
A proposed mechanism does not show that the effect happens in people.
Aloe gel should not be put on a deep or infected wound without medical advice; one trial found delayed healing of an open surgical wound.
Plaque psoriasis: calming skin plaques
Mixed findingsTrials of aloe vera gel or cream on plaque psoriasis disagree. One found a very large effect, one found the gel did slightly worse than placebo, and one found a cream did a little better than a steroid cream.
5 studies0.5% aloe vera extract in a hydrophilic cream; a commercial preserved…
Studies, doses and limits
What the trials found
A Pakistani trial (Syed 1996; 60 patients) of 0.5% aloe vera extract in a cream reported 25 of 30 'cured' versus 2 of 30 with placebo. A Danish double-blind right/left trial (Paulsen 2005; 41 patients) of a commercial aloe vera gel found that psoriasis scores fell in 72.5% of aloe sites but 82.5% of placebo sites, a result significantly in favour of placebo (P = 0.0197), and 55% reported local side effects, mostly dryness. A Thai double-blind trial (Choonhakarn 2010; 80 patients) compared aloe vera cream with 0.1% triamcinolone cream for 8 weeks: PASI fell from 11.6 to 3.9 with aloe and from 10.9 to 4.3 with the steroid, with no placebo group. A 2021 nursing meta-analysis (Gok Metin) pooled two psoriasis studies and found lower PASI with aloe gel.
Results
Mixed. The largest effect (Syed) has not been repeated in the trials we read, and the one properly placebo-controlled Western trial (Paulsen) did not favour aloe.
Effect sizes as reported
Syed: cured 83.3% vs 6.6% (P < 0.001). Paulsen: score sum fell in 72.5% (aloe) vs 82.5% (placebo) of sites, P = 0.0197 favouring placebo. Choonhakarn: between-group PASI difference 1.1 (95% CI -2.13 to -0.16, P = 0.0237); DLQI difference 0.3 (P = 0.5497). Gok Metin: PASI SMD -1.32 (95% CI -1.86 to -0.78), two studies.
Why this rating
The trials point in opposite directions, used different aloe products and strengths, and the pooled result rests on two studies.
Form and dose studied
0.5% aloe vera extract in a hydrophilic cream; a commercial preserved aloe vera gel; an aloe vera cream.
Who was studied
Adults with stable mild-to-moderate plaque psoriasis.
Limits
Different products, small trials, one trial had no placebo group, and treatment periods were 4 to 8 weeks. Industry or product links were not stated in the abstracts.
Why researchers looked
Psoriasis plaques are itchy, scaly and hard to treat, and people look for gentle options.
Traditional use
Aloe leaf gel is a traditional skin remedy. This is a traditional use.
Proposed mechanism Preliminary mechanism
Aloe gel contains sugars and other compounds that calm inflammation in lab models. How that would act on psoriasis plaques has not been shown.
A proposed mechanism does not show that the effect happens in people.
Dryness was the most common local effect in the placebo-controlled trial. Do not stop prescribed psoriasis treatment without talking to your doctor.
Skin reactions during radiotherapy: prevention
Mixed findingsAloe vera gel has not been shown to prevent radiotherapy skin burns. The two largest trials, in about 300 women having breast radiotherapy, found no difference. A newer head-and-neck trial found less redness and wet peeling in some weeks but not on its main score.
4 studiesAloe vera gel on the skin during radiotherapy; products varied.
Studies, doses and limits
What the trials found
Two North American phase III trials (Williams 1996; 194 women with placebo gel and 108 women versus no treatment) found virtually identical skin scores with aloe vera gel and without it, and rare contact dermatitis from the gel. A systematic review (Richardson 2005; 5 published and 2 unpublished trials) found no evidence that topical aloe prevents or reduces radiation skin reactions. A Thai double-blind trial in 120 people with head and neck cancer on chemoradiation (Tungkasamit 2022) found no difference in median skin scores over 8 weeks, but moderate-to-severe redness was less common in weeks 5 and 6 and moist peeling was less common in week 7; its authors still state that aloe vera gel showed no prophylactic efficacy against radiation dermatitis compared with placebo.
Results
Mostly null. The one trial with some positive secondary findings did not meet its main aim.
Effect sizes as reported
Williams: skin dermatitis scores 'virtually identical' in both trials. Tungkasamit: moderate-to-severe erythema 13.6% vs 27.8% (week 5, P = 0.05) and 24.1% vs 42.6% (week 6, P = 0.038) for aloe vs placebo; median RISRAS not significantly different weeks 1 to 8.
Why this rating
The older large trials and a systematic review were null, and the newest trial is positive on some secondary measures only. Overall there is no reliable evidence of benefit.
Form and dose studied
Aloe vera gel on the skin during radiotherapy; products varied.
Who was studied
Women having breast or chest-wall radiotherapy; adults with head and neck cancer having chemoradiation.
Limits
Different products, abstracts only, and the newest trial's own conclusion is internally mixed.
Why researchers looked
Many people ask whether a plant gel can protect skin during cancer radiotherapy.
Traditional use
Cooling aloe gel is a traditional remedy for burns. This is a traditional use.
Proposed mechanism Pharmacological theory
No specific mechanism has been shown in people. Aloe gel is thought to soothe inflamed skin.
A proposed mechanism does not show that the effect happens in people.
Always ask the radiotherapy team before putting anything on skin that is being treated. Rare contact dermatitis was seen from the gel.
Bowel irritation after pelvic radiotherapy: acute radiation proctitis
Very low certaintyOne very small trial of an aloe vera ointment in 20 people having pelvic radiotherapy found less severe proctitis, with better diarrhoea symptoms and mood scores. It is too small to rely on.
1 studies3% aloe vera ointment (type of aloe preparation not described in the …
Studies, doses and limits
What the trials found
In a preliminary randomized placebo-controlled trial (Sahebnasagh 2022), 20 colorectal cancer patients receiving radiotherapy used 3% aloe vera ointment or placebo, 1 g twice daily for 6 weeks. The diarrhoea symptom score improved (P = 0.029), quality of life and depression scores improved, and CRP fell, while formal toxicity measures did not differ significantly.
Results
Favourable on several scores, but toxicity grading was not significantly different.
Effect sizes as reported
Diarrhoea symptom score P = 0.029 before vs after treatment with aloe; toxicity measures not significantly different between groups.
Why this rating
Twenty people, one small trial, several outcomes measured and only some significant.
Form and dose studied
3% aloe vera ointment (type of aloe preparation not described in the abstract).
Who was studied
Adults with colorectal cancer having radiotherapy.
Limits
Tiny preliminary trial; abstract only.
Why researchers looked
Radiotherapy to the pelvis can inflame the lower bowel, and aloe is a traditional soothing remedy.
Traditional use
Soothing plant gels have long been used on irritated tissue. This is a traditional use.
Proposed mechanism Pharmacological theory
Not established. Aloe gel is proposed to calm inflammation.
A proposed mechanism does not show that the effect happens in people.
Use only under the cancer team's guidance.
Acne vulgaris: added to a tretinoin cream
Low certaintyIn one trial of 60 people with mild-to-moderate acne, adding a 50% aloe vera gel to tretinoin cream reduced pimple counts more than tretinoin plus a dummy gel. Aloe on its own was not tested.
2 studies50% aloe vera leaf gel with 0.05% tretinoin cream.
Studies, doses and limits
What the trials found
An 8-week randomized double-blind trial (Hajheydari 2014; 60 people) compared 0.05% tretinoin cream plus 50% aloe vera leaf gel with tretinoin plus placebo. The combination reduced non-inflammatory, inflammatory and total lesion scores more, and redness was less severe. Scaling was the most common side effect. NCCIH says two small studies suggest aloe gel combined with other treatments may improve acne.
Results
Better lesion scores with the combination; aloe alone untested.
Effect sizes as reported
Non-inflammatory lesions P = 0.001, inflammatory P = 0.011, total P = 0.003 versus control; erythema P = 0.046. Effect sizes in lesion counts not given in the abstract.
Why this rating
One small trial of a combination, results given as p-values only.
Form and dose studied
50% aloe vera leaf gel with 0.05% tretinoin cream.
Who was studied
People with mild to moderate acne.
Limits
One trial, combination with a drug, short, abstract only.
Why researchers looked
Tretinoin often irritates skin, and a soothing plant gel might help people tolerate it.
Traditional use
Aloe gel is a traditional skin soother. This is a traditional use.
Proposed mechanism Pharmacological theory
Not shown. Possible calming and moisturising effects on irritated skin.
A proposed mechanism does not show that the effect happens in people.
Scaling and redness are possible; tretinoin itself has precautions in pregnancy that are unrelated to aloe.
Oral lichen planus: mouth sores
Low certaintyAloe vera gel in the mouth looks promising for oral lichen planus in small trials, with results roughly like a steroid ointment in some and worse in the pooled analysis. The evidence is weak.
3 studiesAloe vera gel applied to the mouth.
Studies, doses and limits
What the trials found
A 2017 systematic review and meta-analysis (Ali; 5 clinical trials and 2 case reports) found weak evidence that aloe vera beats placebo and works about as well as triamcinolone, but the pooled analysis was heterogeneous and showed aloe vera inferior to the control overall. A 2012 trial (Reddy; 40 patients) reported aloe gel more effective than triamcinolone ointment after 8 weeks. NCCIH lists lichen planus among uses with a small amount of research.
Results
Weak, inconsistent evidence; steroids remain the standard.
Effect sizes as reported
Not available as a single number; the meta-analysis reported heterogeneity and aloe vera inferior to controls overall. Reddy: aloe more effective than triamcinolone (no numbers in abstract).
Why this rating
Reviewers themselves called the evidence weak and the pooled result heterogeneous; trials small.
Form and dose studied
Aloe vera gel applied to the mouth.
Who was studied
Adults with symptomatic oral lichen planus.
Limits
Small trials, different products and measures; abstracts only.
Why researchers looked
Standard treatment is a steroid, which can cause side effects such as thrush, so gentler options are sought.
Traditional use
Aloe gel is traditionally used for mouth sores. This is a traditional use.
Proposed mechanism Preliminary mechanism
Aloe sugars calm inflammation in lab tests. Not shown in lichen planus.
A proposed mechanism does not show that the effect happens in people.
A persistent mouth sore needs a dentist or doctor to check it.
Oral submucous fibrosis: mouth burning and stiffness
Low certaintyIn a pooled analysis of six trials, aloe vera reduced mouth pain or burning at one and two months but not at three months, and did not clearly improve objective mouth opening or signs.
2 studiesAloe vera gel or other aloe preparations for the mouth.
Studies, doses and limits
What the trials found
A 2019 systematic review and meta-analysis (Al-Maweri; 6 randomized trials) found significantly less pain/burning with aloe vera at the end of the first and second month, but no significant difference at three months, and no significant difference in objective clinical outcomes. The authors noted marked differences between studies. NCCIH lists oral submucous fibrosis among uses with a small amount of research.
Results
Short-term symptom relief, no clear objective gain.
Effect sizes as reported
Not given as numbers in the abstract.
Why this rating
Six small trials with marked heterogeneity and no objective benefit.
Form and dose studied
Aloe vera gel or other aloe preparations for the mouth.
Who was studied
Adults with oral submucous fibrosis.
Limits
Heterogeneous trials and abstract only.
Why researchers looked
This chewing-tobacco and betel-nut related condition is hard to treat.
Traditional use
Aloe is a traditional soothing remedy. This is a traditional use.
Proposed mechanism Preliminary mechanism
Anti-fibrosis effects have been proposed from lab and animal work but were not shown here.
A proposed mechanism does not show that the effect happens in people.
Stopping tobacco and betel-nut use matters more; see a dentist.
Mouth sores from cancer treatment: oral mucositis
Low certaintyA 2025 pooled analysis of seven trials found that aloe vera reduced the number of severe (grade 3 and 4) mouth sores in people having radiotherapy or chemotherapy, compared with placebo, but not compared with sodium bicarbonate or benzydamine.
2 studiesAloe vera mouth preparations; forms varied.
Studies, doses and limits
What the trials found
The 2025 meta-analysis (Cássia-Santos; 7 trials, 355 participants) found fewer severe cases with aloe vera than control (OR 0.32, 95% CI 0.15 to 0.70). In the subgroup compared with placebo the odds ratio was 0.22 (95% CI 0.11 to 0.44), but there was no significant difference against sodium bicarbonate or benzydamine. A 2021 review (Gok Metin) also noted reduced mucositis in three studies.
Results
Fewer severe cases versus placebo only.
Effect sizes as reported
OR 0.32 (95% CI 0.15 to 0.70, P = 0.004); versus placebo OR 0.22 (95% CI 0.11 to 0.44).
Why this rating
Seven small trials, moderate heterogeneity (I2 36%), and the benefit disappears against active comparison mouthwashes.
Form and dose studied
Aloe vera mouth preparations; forms varied.
Who was studied
Cancer patients having radiotherapy or chemotherapy.
Limits
Abstract only; trial quality not stated in the abstract.
Why researchers looked
Painful mouth sores are a common cancer-treatment side effect, and options are limited.
Traditional use
Aloe is a traditional mouth soother. This is a traditional use.
Proposed mechanism Pharmacological theory
Not established in people.
A proposed mechanism does not show that the effect happens in people.
Ask the cancer team before using mouth products.
Gum inflammation and dental plaque: aloe mouthwash and toothpaste
Low certaintyAloe vera mouthwash seems about as good as chlorhexidine for gum inflammation but not as good for plaque, with fewer side effects. Aloe toothpaste results are not reliable.
2 studiesAloe vera mouthwash or aloe-containing toothpaste.
Studies, doses and limits
What the trials found
A 2020 systematic review (Al-Maweri; 6 randomized trials, 1,358 people) of aloe vera mouthwash versus chlorhexidine found that four trials judged aloe as effective as chlorhexidine for plaque and two found chlorhexidine significantly better; for gum inflammation three trials found comparable results and one favoured chlorhexidine; aloe had no or minimal side effects, while chlorhexidine caused staining and taste change. The authors called the evidence inconclusive and preliminary. A 2014 review of aloe vera toothpastes (Dhingra; 2 trials) found them similar to control toothpaste with high risk of bias.
Results
Comparable to chlorhexidine for gum inflammation, inferior for plaque.
Effect sizes as reported
Counts of trials only; no pooled numbers in the abstracts.
Why this rating
The reviewers called the evidence inconclusive and preliminary; toothpaste trials had high risk of bias.
Form and dose studied
Aloe vera mouthwash or aloe-containing toothpaste.
Who was studied
Adults and school children with gum inflammation.
Limits
Different formulations; abstracts only.
Why researchers looked
Chlorhexidine mouthwash stains teeth and changes taste, so alternatives are of interest.
Traditional use
Aloe gel has been used in the mouth traditionally. This is a traditional use.
Proposed mechanism Laboratory research
Lab studies suggest aloe has antibacterial and calming effects. Not proven in the mouth.
A proposed mechanism does not show that the effect happens in people.
A mouthwash is not a replacement for brushing and dental care.
Gum disease (periodontitis): aloe gel placed in the gum pockets
Very low certaintyA pooled analysis of three trials found small improvements in gum pocket depth and attachment when aloe vera gel was added to standard deep cleaning, but the reviewers said the evidence was not reliable enough to give advice.
1 studiesAloe vera gel placed in gum pockets as an add-on to deep cleaning.
Studies, doses and limits
What the trials found
The 2025 meta-analysis (Xie; 3 randomized trials) found adding aloe vera to scaling and root planing reduced probing pocket depth (MD -0.47 mm at 3 months, -0.29 at 6, -1.06 at 12) and improved clinical attachment level at 6 and 12 months, with no difference in plaque or bleeding at 6 months. The authors state that the quality and number of studies mean the evidence was not reliable enough to support clinical advice.
Results
Small statistically significant gains in three trials.
Effect sizes as reported
PPD MD -0.47 (95% CI -0.78 to -0.16) at 3 months; -0.29 (-0.53 to -0.06) at 6; -1.06 (-2.04 to -0.08) at 12. CAL MD -0.56 (-0.85 to -0.27) at 6; -0.98 (-1.28 to -0.68) at 12. Bleeding index MD -0.40 (-0.62 to -0.18) at 12 months.
Why this rating
Only three trials, and the authors say the evidence is not reliable enough for advice.
Form and dose studied
Aloe vera gel placed in gum pockets as an add-on to deep cleaning.
Who was studied
Adults with periodontitis.
Limits
Three studies, abstract only.
Why researchers looked
Gel placed in gum pockets after cleaning might help healing.
Traditional use
Not a traditional use in the strict sense.
Proposed mechanism Pharmacological theory
Not established.
A proposed mechanism does not show that the effect happens in people.
Gum disease needs a dentist.
Sunburn: prevention and treatment
Evidence againstAloe vera cream did not protect against sunburn or tanning and did not treat sunburn better than placebo in a small trial. This is evidence against the common belief.
1 studies70% aloe vera cream.
Studies, doses and limits
What the trials found
In a randomized double-blind trial of 20 volunteers (Puvabanditsin 2005) with a 70% aloe vera cream, there was no sunburn or tan protection and no benefit for sunburn treatment compared with placebo.
Results
No benefit over placebo.
Effect sizes as reported
No numbers in abstract.
Why this rating
A small but direct test found no effect; no larger trial was found.
Form and dose studied
70% aloe vera cream.
Who was studied
20 volunteers exposed to UVB.
Limits
Small and old; abstract only. Cooling comfort was not the outcome.
Why researchers looked
Aloe is the classic after-sun product.
Traditional use
Aloe gel on sunburn is a widespread folk use. This is a traditional use.
Proposed mechanism Pharmacological theory
Cooling and moisturising effects are proposed. Not shown to reduce UV damage.
A proposed mechanism does not show that the effect happens in people.
Use sunscreen and sun protection instead of relying on aloe.
Blood sugar in prediabetes and type 2 diabetes: aloe vera taken by mouth
Low certaintyPooled analyses of small trials found that aloe vera taken by mouth lowered fasting blood sugar and HbA1c in people with prediabetes or type 2 diabetes. The trials used many different products and were very uneven, so the size of the effect is uncertain.
6 studiesOral aloe vera gel, juice or capsules of varied makeup; trials used d…
Studies, doses and limits
What the trials found
A 2016 meta-analysis (Suksomboon; 8 trials, 470 people) found that in prediabetes aloe vera lowered fasting plasma glucose by 0.22 mmol/L with no effect on HbA1c, while in type 2 diabetes the fall in fasting glucose was marginal (about 1.17 mmol/L, borderline) and HbA1c fell by 11 mmol/mol. The authors cited high heterogeneity and called for standardized, well-powered trials. A second 2016 meta-analysis (Dick; 9 studies for glucose, n = 283; 5 for HbA1c, n = 89) found larger falls (46.6 mg/dL fasting glucose, 1.05 percentage points of HbA1c) but showed publication bias for fasting glucose. A 2021 overview of four systematic reviews (Araya-Quintanilla) called the evidence moderate to high quality in favour of aloe in type 2 diabetes and prediabetes. NCCIH says a small amount of research suggests oral aloe may lower blood sugar and HbA1c.
Results
Consistent direction in pooled analyses, but sizes range from small to large depending on the review.
Effect sizes as reported
Prediabetes: fasting plasma glucose MD -0.22 mmol/L (95% CI -0.32 to -0.12); HbA1c MD -2 mmol/mol (95% CI -5 to 1). Type 2 diabetes: FPG MD -1.17 mmol/L (95% CI -2.35 to 0.00); HbA1c MD -11 mmol/mol (95% CI -19 to -2). Dick: fasting glucose -46.6 mg/dL (p < 0.0001); HbA1c -1.05% (p = 0.004).
Why this rating
The overview of reviews rated the evidence moderate to high, but the individual reviews report high heterogeneity, publication bias (Dick) and mixed products, so we rate it lower. We did not read which aloe parts (gel, whole leaf) each trial used.
Form and dose studied
Oral aloe vera gel, juice or capsules of varied makeup; trials used different products.
Who was studied
Adults with prediabetes or type 2 diabetes, mostly small trials.
Limits
Heterogeneity, publication bias, unknown content of products, short trials. Blood sugar markers are not the same as fewer complications.
Why researchers looked
Aloe has a folk reputation for diabetes, and its gel sugars may slow how fast the gut takes up sugar.
Traditional use
Aloe is used in folk medicine for diabetes in several regions. This is a traditional use.
Proposed mechanism Preliminary mechanism
A review of lab and animal work suggests that aloe gel sugar (acemannan) can slow digestion and the release of sugar from starch. This has not been shown to explain the results in trials.
A proposed mechanism does not show that the effect happens in people.
Oral aloe products that contain latex can cause diarrhoea and potassium loss, and some cause liver injury (see the safety file). Aloe could add to blood-sugar medicines; talk to your doctor.
Body weight and fat in people with obesity and prediabetes
Low certaintyOne 8-week trial of a specific aloe vera gel complex in 136 people with obesity and prediabetes or early diabetes found lower body weight and body fat than control. It has not been repeated in the studies we read.
2 studiesAloe QDM complex, an aloe vera gel complex (exact makeup not describe…
Studies, doses and limits
What the trials found
The randomized controlled trial (Choi 2013; 136 obese adults with prediabetes or early untreated diabetes) of an aloe vera gel complex (Aloe QDM complex) found at 8 weeks significantly lower body weight (P = 0.02) and body fat mass (P = 0.03), and lower insulin and HOMA-IR at 4 weeks, but not a significant between-group difference in fasting glucose. NCCIH notes one small study with modest weight and fat-mass reduction.
Results
Modest improvements in a single trial of a named product.
Effect sizes as reported
Weight P = 0.02; fat mass P = 0.03 at 8 weeks; insulin P = 0.04 and HOMA-IR P = 0.047 at 4 weeks; fasting glucose between-group difference not significant (P = 0.16).
Why this rating
One trial of one product; the amount of change is not in the abstract; no repeat trial read.
Form and dose studied
Aloe QDM complex, an aloe vera gel complex (exact makeup not described in the abstract).
Who was studied
Obese adults with prediabetes or early untreated diabetes.
Limits
Single trial, short, a branded product, abstract only; 14 people were lost to follow-up.
Why researchers looked
Oral aloe is promoted for weight loss.
Traditional use
Not a documented traditional use for weight loss.
Proposed mechanism Pharmacological theory
Unknown. Sugar and satiety effects of aloe gel polysaccharides have been proposed in reviews.
A proposed mechanism does not show that the effect happens in people.
See the safety file for oral aloe products.
Irritable bowel syndrome (IBS): symptom relief
Low certaintyA pooled analysis of three small trials found that aloe vera improved IBS symptoms more than placebo over a short time with no related side effects. The numbers are small, and NCCIH says there is not enough reliable information.
2 studiesOral aloe vera preparations (the abstract does not say which); this f…
Studies, doses and limits
What the trials found
A 2018 meta-analysis of 3 randomized placebo-controlled trials (Hong; 151 people with IBS) found a significant improvement in symptom score (standardized mean difference 0.41; 95% CI 0.07 to 0.75), a higher response rate (risk ratio 1.69; 95% CI 1.05 to 2.73), and no aloe-related adverse events. The authors declared no conflicts. NCCIH says there is not enough reliable information on aloe for IBS.
Results
Modest benefit over placebo in very small trials.
Effect sizes as reported
SMD 0.41 (95% CI 0.07 to 0.75, P = 0.020); response RR 1.69 (95% CI 1.05 to 2.73).
Why this rating
Three small trials (151 people), short, and lower end of the confidence interval close to no effect.
Form and dose studied
Oral aloe vera preparations (the abstract does not say which); this finding does not apply to aloe latex.
Who was studied
Adults with IBS.
Limits
Three trials, small, products not described in the abstract.
Why researchers looked
Aloe is a traditional gut remedy and people with IBS seek natural options.
Traditional use
Aloe has traditional use for digestive complaints. This is a traditional use.
Proposed mechanism Pharmacological theory
Not established. Aloe gel is proposed to soothe the gut lining; anthraquinones in latex have a laxative action, which is a different effect.
A proposed mechanism does not show that the effect happens in people.
Do not use aloe latex products for IBS: they act as strong laxatives and can worsen cramps.
Constipation: aloe LATEX and dried leaf juice (not the gel) as a laxative
Low certaintyThis use belongs to the bitter yellow latex under the leaf skin, not to the clear gel. Its anthraquinones (such as aloin) act as a strong stimulant laxative. Europe lists it only for short-term occasional constipation, and the US FDA took aloe out of over-the-counter laxatives in 2002 for lack of safety data.
3 studiesDried aloe leaf juice / latex products (stimulant laxatives). Clear a…
Studies, doses and limits
What the trials found
The EU herbal monograph (EMA/HMPC/625788/2015, adopted 22 November 2016) accepts the dried leaf juice of Aloe barbadensis and cape aloes for short-term use in occasional constipation, for adolescents over 12 and adults, not for more than one week. A 28-day double-blind trial of a combination capsule of celandine, aloe vera and psyllium in 35 adults with chronic constipation (Odes 1991) found more frequent bowel movements, softer stools and less laxative dependence than placebo, with no change in abdominal pain. We read no trial of aloe latex alone.
Results
A laxative effect is expected and accepted by EMA, but the safety limits are strict.
Effect sizes as reported
Not given as numbers in the abstract.
Why this rating
Based on regulatory acceptance and one small combination-product trial; no aloe-only trial was read.
Form and dose studied
Dried aloe leaf juice / latex products (stimulant laxatives). Clear aloe gel does not act this way.
Who was studied
Adults and adolescents over 12 (EU monograph); not children under 12, pregnancy or breastfeeding.
Limits
Combination trial included celandine and psyllium, which have their own actions. Abstract only. Long-term use harms (see safety file).
Why researchers looked
Aloe latex has been used as a laxative for a very long time.
Traditional use
Aloe dried juice (bitter aloes) is a long-standing traditional laxative. The EU monograph recognises it for short-term occasional constipation.
Proposed mechanism Authoritative guidance
Aloins reach the large bowel unabsorbed; gut bacteria convert them to aloe-emodin anthrone, which speeds bowel movement and draws water and salts into the bowel. A bowel movement follows after about 6 to 12 hours (EMA monograph).
A proposed mechanism does not show that the effect happens in people.
Cramps and diarrhoea, potassium loss, and dependence with long use. Contraindicated in pregnancy, breastfeeding and under age 12 (EMA). The US FDA removed aloe from OTC laxatives in 2002 (via NCCIH).
Ulcerative colitis: oral aloe vera gel
Low certaintyOne small 4-week trial found oral aloe vera gel produced a clinical response more often than placebo in mild-to-moderate ulcerative colitis, but full remission and the bowel-scope findings did not differ significantly. NCCIH says there is not enough reliable information.
3 studiesOral aloe vera gel (inner-leaf gel, 100 mL twice daily for 4 weeks in…
Studies, doses and limits
What the trials found
In the randomized double-blind placebo-controlled trial (Langmead 2004; 44 evaluable outpatients with mild-to-moderate active ulcerative colitis, 2:1 randomization) of oral aloe vera gel for 4 weeks, clinical remission occurred in 9/30 (30%) versus 1/14 (7%) (P = 0.09), improvement in 11/30 (37%) versus 1/14 (7%) (P = 0.06) and response in 14/30 (47%) versus 2/14 (14%) (P < 0.05). Clinical and histological scores fell with aloe, but sigmoidoscopic scores and lab markers did not differ. Adverse events were minor and similar in both groups.
Results
A higher response rate on one measure; remission and endoscopy not significant.
Effect sizes as reported
Response 47% vs 14% (OR 5.3, 95% CI 1.0 to 27, P < 0.05); remission 30% vs 7% (OR 5.6, 95% CI 0.6 to 49, P = 0.09).
Why this rating
One small single-centre trial (44 patients); wide confidence intervals; main endpoints not met.
Form and dose studied
Oral aloe vera gel (inner-leaf gel, 100 mL twice daily for 4 weeks in the trial). Not aloe latex, which is contraindicated in inflammatory bowel disease by EMA.
Who was studied
Adults with mild-to-moderate active ulcerative colitis.
Limits
Small, short; abstract only; the sigmoidoscopy results were negative.
Why researchers looked
Aloe is claimed to be anti-inflammatory, and many bowel disease patients use it.
Traditional use
Aloe is used in folk gut medicine. This is a traditional use.
Proposed mechanism Animal research
Not shown in people. Lab and animal work suggests aloe gel can protect the gut lining in rats with induced colitis.
A proposed mechanism does not show that the effect happens in people.
Aloe latex products are contraindicated in inflammatory bowel disease (EMA). Do not replace prescribed colitis treatment.
Acid reflux (GERD): aloe vera syrup
Very low certaintyA small pilot trial of an aloe vera syrup in 79 people with reflux symptoms reported fewer symptoms over 4 weeks, compared against omeprazole and ranitidine rather than placebo. It is too early to say it works.
1 studiesAloe vera syrup standardised to polysaccharide (plant part not stated…
Studies, doses and limits
What the trials found
A pilot randomized positive-controlled trial (Panahi 2015; 79 people) compared an aloe vera syrup (standardised to 5.0 mg polysaccharide per mL) with omeprazole or ranitidine for 4 weeks. The syrup reduced the frequency of all eight GERD symptoms measured, with no adverse events requiring withdrawal. There was no placebo group.
Results
Symptom frequency fell; no placebo comparison.
Effect sizes as reported
Not given as numbers in the abstract.
Why this rating
Small pilot, no placebo group, no numbers in the abstract.
Form and dose studied
Aloe vera syrup standardised to polysaccharide (plant part not stated in the abstract).
Who was studied
Adults with GERD symptoms.
Limits
Pilot, no placebo, abstract only.
Why researchers looked
Aloe gel is thought to soothe the gullet.
Traditional use
Folk use for stomach complaints. This is a traditional use.
Proposed mechanism Pharmacological theory
Not established.
A proposed mechanism does not show that the effect happens in people.
Persistent reflux needs a doctor.
Blood fats (cholesterol and triglycerides)
Not enough evidenceThere is no reliable evidence yet that aloe vera lowers cholesterol. The reviews we read gave few usable numbers.
3 studiesVarious oral aloe products.
Studies, doses and limits
What the trials found
An overview of four systematic reviews (Araya-Quintanilla 2021) reported a triglyceride mean difference of -4.99 (P = 0.000), but the abstract does not give units or which group. A 2022 review (Deora) says studies on aloe in diabetic dyslipidemia are scanty. A 15-person crossover trial of two aloe preparations in healthy people (Yun 2010) measured blood lipids, but the abstract does not report the result.
Results
Not enough numbers to judge.
Effect sizes as reported
Triglycerides MD -4.99 (units not stated in abstract).
Why this rating
The abstracts give no clear lipid results we could use.
Form and dose studied
Various oral aloe products.
Who was studied
People with diabetes or prediabetes; healthy volunteers.
Limits
Abstracts only; full texts would be needed.
Why researchers looked
Aloe is claimed to improve blood fats, especially in people with diabetes.
Traditional use
Not a well-documented traditional use.
Proposed mechanism Pharmacological theory
Review authors propose indirect effects through better blood sugar control.
A proposed mechanism does not show that the effect happens in people.
Do not stop cholesterol medicines.
Vitamin C and B12 levels when taken with aloe
Very low certaintyIn a small crossover trial of 15 healthy volunteers, drinking aloe gel with vitamins C and B12 gave higher blood levels of both vitamins than water did. This does not show a health benefit.
1 studiesAloe inner-leaf gel and decolorized whole-leaf aloe, taken with vitam…
Studies, doses and limits
What the trials found
In a randomized placebo-controlled crossover trial (Yun 2010; 15 healthy adults), either an aloe inner-leaf gel or a whole-leaf decolorized aloe preparation was taken with vitamin B12 1 mg and vitamin C 500 mg, versus water. The gel raised plasma vitamin C at 4, 6, 8 and 24 hours, the whole-leaf form at 4 and 6 hours, and both raised vitamin B12 at 1 and 2 hours (P < 0.01). Antioxidant capacity (ORAC) also rose. The authors concluded both preparations were safe and well tolerated.
Results
Higher short-term blood vitamin levels.
Effect sizes as reported
P < 0.01 for vitamin C and B12 at the times listed; values not given in the abstract.
Why this rating
Fifteen healthy people, short follow-up, abstract numbers missing, and the clinical meaning is unknown.
Form and dose studied
Aloe inner-leaf gel and decolorized whole-leaf aloe, taken with vitamins.
Who was studied
Healthy adults.
Limits
Small, surrogate blood levels only; abstract only.
Why researchers looked
Aloe has been claimed to help the body absorb nutrients.
Traditional use
Not a traditional use.
Proposed mechanism Pharmacological theory
Unknown.
A proposed mechanism does not show that the effect happens in people.
High vitamin doses were used in the trial.
Connections to the rest of health
How Aloe Vera connects to the rest of our health knowledge graph. Every link says what kind of connection it is. A safety link (for example to the liver) is a warning, not a benefit. A study that merely mentions a topic never creates a benefit link.
Explore every connection: goals, body systems, organs, symptoms, genes
A. Wellness goals
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Healthy Skin | Potential benefit | Low certainty | Minor burns (first- and second-degree): faster healing: Aloe vera inner-leaf gel put on the skin may help minor burns heal a few days sooner than other dressings. The trials are small and varied, and an older Cochrane review of wounds called the evidence too weak to rely on. Pain relief is not shown. Other wounds: skin-graft donor sites, post-surgery wounds and diabetic foot ulcers: For wounds other than minor burns the picture is thin and mixed. A small trial found skin-graft donor sites healed about two days sooner, two small trials in diabetic foot ulcers were positive, and the Cochrane review found trial quality too poor to say, with one trial in which aloe delayed the healing of an open surgical wound. | 23 49 33 13 19 64 9 24 34 26 51 41 11 54 46 53 21 42 |
| Inflammation Balance | Potential benefit | Mixed findings | Plaque psoriasis: calming skin plaques: Trials of aloe vera gel or cream on plaque psoriasis disagree. One found a very large effect, one found the gel did slightly worse than placebo, and one found a cream did a little better than a steroid cream. Oral lichen planus: mouth sores: Aloe vera gel in the mouth looks promising for oral lichen planus in small trials, with results roughly like a steroid ointment in some and worse in the pooled analysis. The evidence is weak. | 51 41 11 19 64 3 44 31 59 |
| Gut Health | Potential benefit | Very low certainty | Bowel irritation after pelvic radiotherapy: acute radiation proctitis: One very small trial of an aloe vera ointment in 20 people having pelvic radiotherapy found less severe proctitis, with better diarrhoea symptoms and mood scores. It is too small to rely on. Irritable bowel syndrome (IBS): symptom relief: A pooled analysis of three small trials found that aloe vera improved IBS symptoms more than placebo over a short time with no related side effects. The numbers are small, and NCCIH says there is not enough reliable information. | 48 22 64 31 59 |
| Blood Sugar Balance | Potential benefit | Low certainty | Blood sugar in prediabetes and type 2 diabetes: aloe vera taken by mouth: Pooled analyses of small trials found that aloe vera taken by mouth lowered fasting blood sugar and HbA1c in people with prediabetes or type 2 diabetes. The trials used many different products and were very uneven, so the size of the effect is uncertain. | 50 16 4 10 5 64 |
| Metabolic Health | Potential benefit | Low certainty | Blood sugar in prediabetes and type 2 diabetes: aloe vera taken by mouth: Pooled analyses of small trials found that aloe vera taken by mouth lowered fasting blood sugar and HbA1c in people with prediabetes or type 2 diabetes. The trials used many different products and were very uneven, so the size of the effect is uncertain. Body weight and fat in people with obesity and prediabetes: One 8-week trial of a specific aloe vera gel complex in 136 people with obesity and prediabetes or early diabetes found lower body weight and body fat than control. It has not been repeated in the studies we read. | 50 16 4 10 5 64 |
| Weight Management | Potential benefit | Low certainty | Body weight and fat in people with obesity and prediabetes: One 8-week trial of a specific aloe vera gel complex in 136 people with obesity and prediabetes or early diabetes found lower body weight and body fat than control. It has not been repeated in the studies we read. | 10 64 |
| Digestive Support | Potential benefit | Low certainty | Irritable bowel syndrome (IBS): symptom relief: A pooled analysis of three small trials found that aloe vera improved IBS symptoms more than placebo over a short time with no related side effects. The numbers are small, and NCCIH says there is not enough reliable information. Ulcerative colitis: oral aloe vera gel: One small 4-week trial found oral aloe vera gel produced a clinical response more often than placebo in mild-to-moderate ulcerative colitis, but full remission and the bowel-scope findings did not differ significantly. NCCIH says there is not enough reliable information. | 22 64 31 59 40 |
| Digestive Support | Traditional use | Low certainty | Constipation: aloe LATEX and dried leaf juice (not the gel) as a laxative: This use belongs to the bitter yellow latex under the leaf skin, not to the clear gel. Its anthraquinones (such as aloin) act as a strong stimulant laxative. Europe lists it only for short-term occasional constipation, and the US FDA took aloe out of over-the-counter laxatives in 2002 for lack of safety data. | 59 39 64 |
| Cholesterol Balance | Potential benefit | Not enough evidence | Blood fats (cholesterol and triglycerides): There is no reliable evidence yet that aloe vera lowers cholesterol. The reviews we read gave few usable numbers. | 4 14 57 |
B. Body systems
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Digestive system | Adverse effect or risk | Authoritative guidance | Cramps, diarrhoea, dependence and pseudomelanosis coli; strong stimulant laxative. Preparation or compound: Aloe latex / aloin (dried leaf juice) |
59 64 |
| Hepatic system | Adverse effect or risk | Case report | Acute hepatitis case reports; LiverTox calls it rare. Preparation or compound: Oral aloe products, type not specified |
37 6 56 |
| Urinary system | Adverse effect or risk | Authoritative guidance | Albuminuria, haematuria and electrolyte imbalance (EMA); kidney dysfunction listed by reviews. Preparation or compound: Aloe latex, long use |
59 7 20 |
| Integumentary system | Adverse effect or risk | Rct | Dryness, burning, itching, rare contact dermatitis. Preparation or compound: Topical aloe vera gel |
41 54 18 64 |
| Cardiovascular system | Drug or supplement interaction | Authoritative guidance | Low potassium can strengthen digoxin-type drugs and affect heart rhythm medicines. Preparation or compound: Aloe latex |
59 64 |
| Immune system | Drug or supplement interaction | Case report | Possible bleeding interaction with an anaesthetic reported once. Preparation or compound: Oral aloe vera |
32 |
| Integumentary System | Biological association | Low certainty | Studied for: Minor burns (first- and second-degree): faster healing Studied for: Other wounds: skin-graft donor sites, post-surgery wounds and diabetic foot ulcers | 23 49 33 13 19 64 9 24 34 26 51 41 11 54 46 53 21 42 |
| Immune System | Biological association | Mixed findings | Studied for: Plaque psoriasis: calming skin plaques Studied for: Oral lichen planus: mouth sores | 51 41 11 19 64 3 44 31 59 |
| Digestive System | Biological association | Very low certainty | Studied for: Bowel irritation after pelvic radiotherapy: acute radiation proctitis Studied for: Oral lichen planus: mouth sores | 48 3 44 64 1 12 19 2 15 55 22 59 39 31 40 |
| Endocrine System | Biological association | Low certainty | Studied for: Blood sugar in prediabetes and type 2 diabetes: aloe vera taken by mouth | 50 16 4 10 5 64 |
| Metabolism Weight | Biological association | Low certainty | Studied for: Blood sugar in prediabetes and type 2 diabetes: aloe vera taken by mouth Studied for: Body weight and fat in people with obesity and prediabetes | 50 16 4 10 5 64 14 57 |
| Cardiovascular System | Biological association | Not enough evidence | Studied for: Blood fats (cholesterol and triglycerides) | 4 14 57 |
C. Body parts and organs
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Gut | Adverse effect or risk | Authoritative guidance | Colon is where aloin is converted to its active form and where bowel overgrowth and cancers were seen in rats given non-decolorized whole-leaf extract. Preparation or compound: Aloe latex |
59 8 |
| Liver | Adverse effect or risk | Case report | Liver injury over weeks to years of use. Preparation or compound: Oral aloe products |
37 6 56 64 |
| Kidneys | Adverse effect or risk | Authoritative guidance | Nephropathy in mice with emodin; kidney effects in long-term animal studies; extra caution in kidney disease. Preparation or compound: Aloe latex and emodin-type anthranoids |
59 17 |
| Skin | Adverse effect or risk | Case report | Allergic contact dermatitis case; irritation possibly from latex contamination. Preparation or compound: Aloe leaf juice and gel |
18 36 45 |
I. Biomarkers
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| ALT | Adverse effect or risk | Case report | Liver enzymes were raised in the hepatitis case reports and normalised after stopping. Preparation or compound: Oral aloe products |
6 56 |
| Blood glucose | Drug or supplement interaction | Pharmacological theory | Could add to diabetes medicines; no study of the combination read. Preparation or compound: Oral aloe vera |
50 16 |
| Burn healing time (days) | Biological association | Low certainty | Measured in trials: lowered. A lab change is not the same as a health benefit. | 23 49 33 9 |
| Psoriasis Area and Severity Index (PASI) | Biological association | Mixed findings | Measured in trials: mixed. A lab change is not the same as a health benefit. | 11 41 51 19 |
| Radiation skin reaction score | Biological association | Mixed findings | Measured in trials: no-change. A lab change is not the same as a health benefit. | 54 53 46 |
| Mouth pain or burning (visual analogue scale) | Biological association | Low certainty | Measured in trials: mixed. A lab change is not the same as a health benefit. | 1 19 |
| Severe oral mucositis (grade 3 and 4) | Biological association | Low certainty | Measured in trials: lowered. A lab change is not the same as a health benefit. | 12 |
| Probing pocket depth and clinical attachment level (gum disease) | Biological association | Very low certainty | Measured in trials: lowered. A lab change is not the same as a health benefit. | 55 |
| Acne lesion scores | Biological association | Low certainty | Measured in trials: lowered. A lab change is not the same as a health benefit. | 21 |
| C-reactive protein (CRP) | Biological association | Very low certainty | Measured in trials: lowered. A lab change is not the same as a health benefit. | 48 |
| Fasting blood glucose | Biological association | Low certainty | Measured in trials: lowered. A lab change is not the same as a health benefit. | 50 16 10 4 |
| HbA1c (3-month blood sugar average) | Biological association | Low certainty | Measured in trials: lowered. A lab change is not the same as a health benefit. | 50 16 4 |
| Body weight and body fat mass | Biological association | Low certainty | Measured in trials: lowered. A lab change is not the same as a health benefit. | 10 |
| Fasting insulin and insulin resistance (HOMA-IR) | Biological association | Low certainty | Measured in trials: lowered. A lab change is not the same as a health benefit. | 10 |
| IBS symptom score | Biological association | Low certainty | Measured in trials: lowered. A lab change is not the same as a health benefit. | 22 |
| Colitis activity (Simple Clinical Colitis Activity Index and histology) | Biological association | Low certainty | Measured in trials: mixed. A lab change is not the same as a health benefit. | 31 |
| Plasma vitamin C and vitamin B12 | Biological association | Very low certainty | Measured in trials: raised. A lab change is not the same as a health benefit. | 57 |
| Triglycerides | Biological association | Not enough evidence | Measured in trials: mixed. A lab change is not the same as a health benefit. | 4 |
J. Genes, receptors and enzymes
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| TLR5 (Toll-like receptor 5) | Preliminary mechanism | In vitro | Acemannan increased IL-6 and IL-8 in human gum fibroblasts through TLR5, with computer modelling showing binding to its flagellin recognition sites | 52 |
| IL6 (interleukin-6) | Preliminary mechanism | In vitro | Raised by acemannan in mouse macrophages (dose-dependent) and in human gum fibroblasts | 58 52 |
| CXCL8 (interleukin-8) | Preliminary mechanism | In vitro | Raised by acemannan in human gum fibroblasts | 52 |
| TNF (tumour necrosis factor alpha) | Preliminary mechanism | In vitro | Raised by acemannan in the RAW 264.7 mouse macrophage line | 58 |
| FGF7 (keratinocyte growth factor-1) | Preliminary mechanism | In vitro | Expression raised by acemannan in cultured gum fibroblasts | 26 |
| VEGFA (vascular endothelial growth factor) | Preliminary mechanism | Animal | Expression raised by acemannan in cultured gum fibroblasts; improved rat palate wound healing | 26 |
| COL1A1 (type I collagen) | Preliminary mechanism | In vitro | Type I collagen expression raised by acemannan in cultured gum fibroblasts | 26 |
K. Biological pathways
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| NF-kB signalling | Preliminary mechanism | In vitro | Acemannan raised NF-kB p50/DNA binding in gum fibroblasts; blocking NF-kB abolished the IL-6 and IL-8 rise | 52 |
| Mannose receptor signalling on macrophages and dendritic cells | Preliminary mechanism | In vitro | Proposed in a review for acemannan fragments; results contradictory | 47 |
| Cyclooxygenase and prostaglandin synthesis | Preliminary mechanism | Pharmacological theory | Proposed in a bleeding case report as a way aloe could reduce platelet clumping; unmeasured | 32 |
L. Active compounds
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Aloin A (barbaloin) and aloin B (isobarbaloin) | Biological association | Authoritative guidance | The main laxative compound of aloe latex. It reaches the large bowel and is converted by gut bacteria to aloe-emodin anthrone, which stimulates the bowel (EMA). Its content is the key difference between gel, latex and decolorized products. Preparation or compound: Leaf latex (the bitter yellow juice under the leaf skin) |
59 27 25 |
| Aloe-emodin | Biological association | Animal | Formed by gut bacteria from aloin. In rats about 20 to 30 percent of an oral dose appeared in urine and it was turned quickly into rhein. A review reports poor intestinal absorption, a short half-life and low bioavailability, and hepatotoxicity and nephrotoxicity as main toxicity concerns. EMA cites genotoxic risk for related anthranoids. Preparation or compound: Latex; also formed in the gut from aloin |
30 17 59 25 |
| Aloe-emodin anthrone (aloe-emodin-9-anthrone) | Biological association | Authoritative guidance | The main active laxative form produced by gut bacteria from aloin. How much is absorbed is not known (EMA). Preparation or compound: Formed in the colon from aloin |
59 |
| Emodin | Biological association | Animal | In mice emodin caused kidney damage and in rats it changed oestrous cycle length (EMA). Several hydroxyanthracene derivatives were genotoxic in vitro. Preparation or compound: Dried leaf juice (described by EMA as a major constituent) |
59 |
| Rhein | Biological association | Animal | In rats aloe-emodin was quickly converted to rhein. After other anthranoids, rhein-type metabolites pass into breast milk in small amounts (EMA). Preparation or compound: Metabolite of aloe-emodin |
30 59 |
| Acemannan | Biological association | In vitro | Called the major carbohydrate fraction of the gel. In mouse macrophage cells it stimulated cytokines; in human gum fibroblasts it raised IL-6 and IL-8 through TLR5 and NF-kB, and in rat palate wounds it improved healing. A 2021 review notes the literature is contradictory. Preparation or compound: Inner-leaf gel |
58 52 26 47 |
| Glucomannan | Biological association | Authoritative guidance | LactMed lists glucomannan and acemannan among the gel's mono- and polysaccharides. No specific activity was read. Preparation or compound: Inner-leaf gel |
36 |
| Allantoin | Biological association | Authoritative guidance | Listed by LactMed among gel ingredients. No specific activity was read. Preparation or compound: Inner-leaf gel |
36 |
| Salicylic acid | Biological association | Authoritative guidance | Listed by LactMed among gel ingredients. A case report suggested aloe may reduce prostaglandin production and platelet clumping (p15292490), which is not shown to come from this compound. Preparation or compound: Inner-leaf gel |
36 32 |
Each connection is stored with the ingredient, the connected record, the kind of connection, the evidence status, the supporting studies, the preparation or compound involved, and a review date (last reviewed October 25, 2026).
Evidence at a glance: what changed in 16 lab markers
Tap a number to show only those markers. Counts are markers, not people.
The evidence
The research centre for Aloe Vera. Every record here was checked against PubMed or the publisher's page; we never list a study we have not verified.
Evidence by outcome
Bars show how many studies we found for each outcome, not how well it works. People are added up across trials only (reviews are not added, to avoid double counting).
How we rate evidence
High certainty
Several well-run trials or reviews agree; further research is unlikely to change the picture much.
Moderate certainty
Good trials point the same way, but some doubt remains.
Low certainty
Small, short or inconsistent trials. The finding could change with better research.
Very low certainty
Very little or very weak human data. Treat as a possibility only.
Mixed findings
Trials or reviews disagree with each other.
Not enough evidence
Not enough human research to say either way.
Evidence against
Good research found no benefit, or found harm.
We take the reviewers' own risk-of-bias and GRADE statements where they exist, and otherwise judge from study size, design, consistency, directness and whether a product matches what is sold. Many publications do not make evidence high. Method note: We searched PubMed, read the EU herbal monograph on aloe dried leaf juice in full, the California Proposition 65 fact sheet, the abstracts of the NTP, LiverTox and LactMed records, and the US National Center for Complementary and Integrative Health page on aloe vera (through a page-summary tool), and checked plant names in GBIF and the NCBI taxonomy and compounds in PubChem. Only abstracts were read for nearly all studies. Some sources were not verified: the full LiverTox chapter, the IARC monograph and the FDA 2002 rule (known only through NCCIH and a review), the German Commission E monograph and the World Health Organization monographs. Certainty ratings are the compiler's own reading, not formal grades. No study is cited that we could not verify.
Study library: every study we checked 65
| Study | Design | People | Product, dose, length | Result |
|---|---|---|---|---|
| Al-Maweri 2019 Aloe vera in treatment of oral submucous fibrosis: A systematic review and meta-analysis. J Oral Pathol Med · PMID 30329174 · DOI |
Meta-analysis |
Oral submucous fibrosis; 6 RCTs | Aloe vera gel or other Varied 1 to 3 months · vs Controls |
Less pain/burning at months 1 and 2; no difference at month 3; no difference in objective signs Not given in abstract Methods, limits and fundingOutcomes: Pain/burning and objective signs Limitations: Marked heterogeneity; abstract only. Read: abstract |
| Al-Maweri 2020 Efficacy of aloe vera mouthwash versus chlorhexidine on plaque and gingivitis: A systematic review. Int J Dent Hyg · PMID 30829440 · DOI |
Systematic review |
1358 People using mouthwash for plaque and gingivitis; 6 RCTs |
Aloe vera mouthwash gel/extract Varied Varied · vs Chlorhexidine mouthwash |
Comparable for gingivitis, inferior for plaque; fewer side effects Not pooled Methods, limits and fundingOutcomes: Plaque scores; gingival inflammation; side effects Limitations: Reviewers call evidence inconclusive; abstract only. Read: abstract |
| Ali 2017 The efficacy of aloe vera in management of oral lichen planus: a systematic review and meta-analysis. Oral Dis · PMID 28029732 · DOI |
Meta-analysis |
Symptomatic oral lichen planus; 5 clinical trials and 2 case reports | Aloe vera gel Varied Varied · vs Placebo or corticosteroid |
Weak evidence aloe better than placebo and comparable to triamcinolone; pooled result inferior to control Not stated in numbers in abstract Methods, limits and fundingOutcomes: Pain and clinical improvement Limitations: Heterogeneous; abstract only. Read: abstract |
| Araya-Quintanilla 2021 Effectiveness of aloe vera in patients with type 2 Diabetes Mellitus and pre-diabetes: An overview of systematic reviews. Diabetes Metab Syndr · PMID 34563809 · DOI |
Systematic review |
Type 2 diabetes and prediabetes; overview of 4 systematic reviews | Aloe vera Varied Varied · vs Controls |
Favoured aloe T2DM FBG SMD -5.61; HbA1c MD -0.95; prediabetes FBG SMD -1.41; HbA1c MD -0.31; TG MD -4.99 (p-values only) Methods, limits and fundingOutcomes: FBG, HbA1c, triglycerides Limitations: Overview of reviews so overlapping trials; authors rate evidence moderate to high. Abstract only. Funding and conflicts: Author(s) declared no conflicts Read: abstract |
| Benzie 2011 Evaluation of the Nutritional and Metabolic Effects of Aloe vera. · PMID 22593933 |
Narrative review |
Book chapter (Benzie and Wachtel-Galor, Herbal Medicine, 2nd ed.) | Aloe vera |
Notes folk uses and few robust clinical investigations n/a Methods, limits and fundingOutcomes: Traditional uses and clinical trials Limitations: Book chapter; only the summary was read. Read: abstract |
| Bottenberg 2007 Oral aloe vera-induced hepatitis. Ann Pharmacother · PMID 17726067 · DOI |
Case report |
1 73-year-old woman with acute hepatitis |
Oral aloe vera capsules (for constipation) |
Liver tests normalised after stopping aloe; causality possible (Naranjo), probable (RUCAM) n/a Methods, limits and fundingOutcomes: Liver markers Limitations: Single case; product not described in abstract. Read: abstract |
| Boudreau 2006 An evaluation of the biological and toxicological properties of Aloe barbadensis (miller), Aloe vera. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev · PMID 16690538 · DOI |
Review |
Review of biological and toxicological properties of Aloe barbadensis | Gel and latex gel; latex |
Ingestion associated with diarrhoea, electrolyte imbalance, kidney dysfunction and drug interactions; contact dermatitis, erythema and phototoxicity from topical use n/a Methods, limits and fundingOutcomes: Toxicity Limitations: Narrative review; 2006; abstract only. Read: abstract |
| Boudreau 2013 Toxicology and carcinogenesis studies of a nondecolorized [corrected] whole leaf extract of Aloe barbadensis Miller (Aloe vera) in F344/N rats and B6C3F1 mice (drinking water study). Natl Toxicol Program Tech Rep Ser · PMID 24042237 |
Animal research animal |
F344/N rats (48 per group) and B6C3F1 mice, 2-year drinking-water study | Nondecolorized whole leaf extract of Aloe barbadensis Miller whole leaf 0.5, 1 or 1.5% in drinking water (rats); 1, 2 or 3% (mice) 2 years · vs Plain drinking water |
Large-intestine cancers in treated male and female rats, none in controls; hyperplasia of large intestine in rats and mice, and of small intestine, stomach and mesenteric lymph nodes in some groups Cancers of the large intestine in rats given the extract Methods, limits and fundingOutcomes: Tumours and hyperplasia in more than 40 tissue sites Limitations: Animal study; abstract of a 266-page report read. Extract was non-decolorized. Read: abstract |
| Burusapat 2018 Topical Aloe Vera Gel for Accelerated Wound Healing of Split-Thickness Skin Graft Donor Sites: A Double-Blind, Randomized, Controlled Trial and Systematic Review. Plast Reconstr Surg · PMID 29649056 · DOI |
Controlled trial |
12 Patients with split-thickness skin graft donor sites (24 sites) |
Topical Aloe vera gel inner-leaf gel Not given in abstract Until epithelialization (about 12 days) · vs Placebo |
Faster epithelialization; no difference in pain 11.5 vs 13.67 days, p < 0.05 Methods, limits and fundingOutcomes: Time to complete epithelialization; pain VAS Limitations: Very small trial; paper also includes a systematic review of 5 trials. Abstract only. Read: abstract |
| Choi 2013 Metabolic effects of aloe vera gel complex in obese prediabetes and early non-treated diabetic patients: randomized controlled trial. Nutrition · PMID 23735317 · DOI |
Controlled trial |
136 Obese adults with prediabetes or early untreated diabetes (14 lost) |
Aloe QDM complex (aloe vera gel complex) gel complex Not given in abstract 8 weeks · vs Control group |
Lower weight and fat mass at 8 weeks; insulin and HOMA-IR lower at 4 weeks Weight P = 0.02; BFM P = 0.03; FBG difference P = 0.16 Methods, limits and fundingOutcomes: Body weight, body fat mass, FBG, insulin, HOMA-IR Limitations: One trial of a branded product; abstract only. Read: abstract |
| Choonhakarn 2010 A prospective, randomized clinical trial comparing topical aloe vera with 0.1% triamcinolone acetonide in mild to moderate plaque psoriasis. J Eur Acad Dermatol Venereol · PMID 19686327 · DOI |
Controlled trial |
80 Adults with mild-to-moderate plaque psoriasis |
Aloe vera cream Not given in abstract 8 weeks · vs 0.1% triamcinolone acetonide cream |
PASI fell 11.6 to 3.9 with aloe and 10.9 to 4.3 with the steroid Between-group PASI difference 1.1; DLQI difference 0.3 (PASI -2.13 to -0.16; DLQI -1.18 to -0.64) Methods, limits and fundingOutcomes: PASI; DLQI Limitations: No placebo group and no follow-up after 8 weeks. Abstract only. Read: abstract |
| Cássia-Santos 2025 Effectiveness of Aloe vera in the treatment of oral mucositis: a systematic review and meta-analysis of randomized controlled trials. Int J Oral Maxillofac Surg · PMID 39909775 · DOI |
Meta-analysis |
355 Cancer patients with oral mucositis; 7 RCTs |
Aloe vera oral preparations Varied Varied · vs Placebo, sodium bicarbonate or benzydamine |
Fewer severe cases with aloe; subgroup shows benefit vs placebo only OR 0.32 overall; OR 0.22 vs placebo (0.15 to 0.70; 0.11 to 0.44) Methods, limits and fundingOutcomes: Severe (grade 3 and 4) mucositis Limitations: Abstract only. Read: abstract |
| Dat 2012 Aloe vera for treating acute and chronic wounds. Cochrane Database Syst Rev · PMID 22336851 · DOI |
Systematic review |
347 People with acute or chronic wounds, 7 RCTs |
Aloe vera products (dressings, gels, mucilage) inner-leaf gel/mucilage (varied) Varied Varied · vs Silver sulfadiazine, other dressings, none |
No gain over silver sulfadiazine for burns; shorter healing after haemorrhoidectomy; no difference in pressure ulcer or biopsy wounds; delayed healing in one surgical-wound trial Burns vs SSD RR 1.41; surgical wounds delayed by mean 30 days (Burns RR 0.70 to 2.85; delayed healing 7.59 to 52.41) Methods, limits and fundingOutcomes: Proportion healed or time to healing Limitations: Cochrane: poor-quality trials with high risk of bias; conclusion is no high-quality evidence for aloe in wounds. Reviewed 2011 literature. Funding and conflicts: Conflict of interest: none known Read: abstract |
| Deora 2022 Aloe vera in diabetic dyslipidemia: Improving blood glucose and lipoprotein levels in pre-clinical and clinical studies. J Ayurveda Integr Med · PMID 36481618 · DOI |
Systematic review |
Diabetic dyslipidemia in pre-clinical and clinical studies | Aloe vera and active components Varied Varied · vs Controls |
Abstract describes aim only Not in abstract Methods, limits and fundingOutcomes: Glucose and lipoproteins Limitations: The abstract states studies on aloe in diabetic dyslipidemia are scanty. Abstract only. Funding and conflicts: Competing interests: none declared Read: abstract |
| Dhingra 2014 Aloe vera herbal dentifrices for plaque and gingivitis control: a systematic review. Oral Dis · PMID 23607360 · DOI |
Systematic review |
Gingivitis; 2 RCTs of aloe vera toothpaste | Aloe vera toothpaste Varied Varied · vs Control toothpaste |
Similar to control toothpaste No difference Methods, limits and fundingOutcomes: Plaque and gingival inflammation Limitations: High risk of bias, missing details. Abstract only. Read: abstract |
| Dick 2016 Reduction of Fasting Blood Glucose and Hemoglobin A1c Using Oral Aloe Vera: A Meta-Analysis. J Altern Complement Med · PMID 27152917 · DOI |
Meta-analysis |
283 Prediabetic and diabetic adults; 9 studies (5 with HbA1c, n = 89) |
Oral aloe vera Varied Varied · vs Controls |
Lower glucose and HbA1c; publication bias for FBG FBG -46.6 mg/dL; HbA1c -1.05% (p < 0.0001; p = 0.004) Methods, limits and fundingOutcomes: FBG, HbA1c Limitations: Publication bias (Egger P = 0.010). Abstract only. Read: abstract |
| Dong 2020 Aloe-emodin: A review of its pharmacology, toxicity, and pharmacokinetics. Phytother Res · PMID 31680350 · DOI |
Review |
Review of aloe-emodin pharmacology, toxicity and PK | Aloe-emodin (isolated) isolated compound |
Hepatotoxicity and nephrotoxicity are the main toxicity concerns reported; poor intestinal absorption, short half-life, low bioavailability n/a Methods, limits and fundingOutcomes: Toxicity and pharmacokinetics Limitations: Isolated compound, not whole aloe; abstract only. Read: abstract |
| Ferreira 2007 Allergic contact dermatitis to Aloe vera. Contact Dermatitis · PMID 17868225 · DOI |
Case report |
1 72-year-old woman with leg dermatitis |
Home-made aloe vera leaf juice on skin leaf |
Positive reactions to aloe leaf, macerated aloe jelly and nickel sulfate n/a Methods, limits and fundingOutcomes: Patch tests Limitations: Single case. Read: abstract |
| Gok Metin 2021 Effects of Aloe vera in adults with mucocutaneous problems: A systematic review and meta-analysis. J Adv Nurs · PMID 33336470 · DOI |
Meta-analysis |
4023 Adults with mucocutaneous problems; 23 trials (6 in meta-analysis) |
Aloe vera in various forms Varied Varied · vs Placebo or other |
No difference in pain; lower PASI in 2 studies; faster healing and less mucositis in narrative synthesis Pain SMD 0.11; PASI SMD -1.32 (Pain -0.37 to 0.59; PASI -1.86 to -0.78) Methods, limits and fundingOutcomes: Pain (VAS), PASI, wound healing, mucositis, quality of life Limitations: Only the abstract was read; includes many conditions and forms. Read: abstract |
| Guo 2016 Aloe vera: A review of toxicity and adverse clinical effects. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev · PMID 26986231 · DOI |
Review |
Review of toxicity and adverse clinical effects of aloe vera | Whole leaf extract, gel, latex whole leaf; gel; latex |
Ingestion linked to diarrhoea, hypokalaemia, pseudomelanosis coli, kidney failure, phototoxicity and hypersensitivity; whole leaf extract carcinogenic in rats and rated IARC Group 2B n/a Methods, limits and fundingOutcomes: Toxicity, genotoxicity, carcinogenicity, adverse clinical effects Limitations: Narrative review; abstract only. Read: abstract |
| Hajheydari 2014 Effect of Aloe vera topical gel combined with tretinoin in treatment of mild and moderate acne vulgaris: a randomized, double-blind, prospective trial. J Dermatolog Treat · PMID 23336746 · DOI |
Controlled trial |
60 People with mild to moderate acne vulgaris |
Aloe vera leaf gel 50% with tretinoin 0.05% leaf gel Topical, regimen not stated in abstract 8 weeks · vs Tretinoin plus vehicle |
Combination reduced lesion scores more Non-inflammatory P = 0.001; inflammatory P = 0.011; total P = 0.003 Methods, limits and fundingOutcomes: Inflammatory and non-inflammatory lesion scores Limitations: Combination with a drug; actual lesion counts not in abstract. Abstract only. Read: abstract |
| Hong 2018 Aloe vera Is Effective and Safe in Short-term Treatment of Irritable Bowel Syndrome: A Systematic Review and Meta-analysis. J Neurogastroenterol Motil · PMID 30153721 · DOI |
Meta-analysis |
151 Adults with irritable bowel syndrome; 3 RCTs |
Oral Aloe vera Varied Short-term · vs Placebo |
Better symptom score and response; no related adverse events SMD 0.41; RR 1.69 (0.07 to 0.75; 1.05 to 2.73) Methods, limits and fundingOutcomes: IBS symptom score; response; adverse events Limitations: Three small trials; products not specified in abstract. Funding and conflicts: Conflicts of interest: none declared Read: abstract |
| Huang 2024 Effects of Aloe vera on Burn Injuries: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Burn Care Res · PMID 38605441 · DOI |
Meta-analysis |
Patients with burn injuries (RCTs); 9 RCTs, 6 with healing data | Topical Aloe vera inner-leaf gel (as described by trials; not specified in abstract) Varied Varied · vs Other topical agents (including antimicrobials) |
Healing shorter with aloe; pain and infection not significantly different Healing MD -3.76 days; pain MD -0.76; infection RR 1.10 (Healing 95% CI -5.69 to -1.84; pain -1.53 to 0.01; infection 0.34 to 3.59) Methods, limits and fundingOutcomes: Wound-healing time; pain; wound infection Limitations: Only the abstract was read. GRADE ratings used but not given in abstract. Mainly second-degree burns. Read: abstract |
| Irani 2024 The Effect of Aloe vera on the Healing of Diabetic Foot Ulcer: A Randomized, Double-blind Clinical Trial. Curr Drug Discov Technol · PMID 37670716 · DOI |
Controlled trial |
66 Patients with diabetic foot ulcers |
Aloe vera gel gel Thin layer under dressing 3 weeks · vs Normal saline and sterile gauze |
Greater fall in score with aloe P-values only in abstract Methods, limits and fundingOutcomes: Bates-Jensen Wound Assessment Tool Limitations: Abstract gives no numbers. Read: abstract |
| Jangra 2022 The dark side of miracle plant-Aloe vera: a review. Mol Biol Rep · PMID 35092563 · DOI |
Review |
Review of the harmful side of aloe vera | Aloe vera compounds various |
Aloin metabolised by gut bacteria to aloe-emodin, linked to carcinogenicity, genotoxicity, nephrotoxicity, purgative effect n/a Methods, limits and fundingOutcomes: Toxicity Limitations: Narrative review; abstract only. Read: abstract |
| Jettanacheawchankit 2009 Acemannan stimulates gingival fibroblast proliferation; expressions of keratinocyte growth factor-1, vascular endothelial growth factor, and type I collagen; and wound healing. J Pharmacol Sci · PMID 19372635 · DOI |
Animal research animal |
Human gingival fibroblasts and male Sprague Dawley rats with hard palate punch wounds | Acemannan (polysaccharide from Aloe vera gel) inner-leaf gel 2 to 16 mg/ml in cells; 0.5%, 1%, 2% gel on wounds 7 days (wounds) · vs Saline, 0.1% triamcinolone, Carbopol vehicle |
Raised proliferation and growth factors; 0.5% acemannan gel gave the best wound healing P < 0.05 Methods, limits and fundingOutcomes: Fibroblast proliferation; KGF-1, VEGF, type I collagen; wound healing Limitations: Cell and animal study. Read: abstract |
| Kaparakou 2021 Quantitative determination of aloin, antioxidant activity, and toxicity of Aloe vera leaf gel products from Greece. J Sci Food Agric · PMID 32643805 · DOI |
Laboratory |
Aloe vera leaf gel products from Greece | Leaf gel products leaf gel |
Aloin below 0.1 mg/L in industrially processed and lab-filtered samples; over 10 mg/L in unprocessed, unfiltered samples n/a Methods, limits and fundingOutcomes: Aloin by liquid chromatography; antioxidant activity; toxicity Limitations: Laboratory analysis of Greek products; not a safety trial. Read: abstract |
| Kim 2023 The absence of genotoxicity of Aloe vera beverages: A review of the literature. Food Chem Toxicol · PMID 36702364 · DOI |
Review |
Review of genotoxicity of aloe vera beverages | Inner leaf gel extract and decolorized whole leaf extract (no more than 10 ppm aloin) inner leaf; whole leaf (decolorized) |
Concluded these products are not genotoxic n/a Methods, limits and fundingOutcomes: Genotoxicity Limitations: Author affiliations not checked for industry ties; declares none. Abstract only. Funding and conflicts: Declared no competing interests Read: abstract |
| Kune 1993 Laxative use not a risk for colorectal cancer: data from the Melbourne Colorectal Cancer Study. Z Gastroenterol · PMID 8465555 |
Observational |
1408 685 colorectal cancer cases and 723 controls |
Laxatives including anthraquinone laxatives various |
Not associated with colorectal cancer n/a Methods, limits and fundingOutcomes: Colorectal cancer risk Limitations: 1993; laxatives in general. Read: abstract |
| Lang 1993 Pharmacokinetic-metabolic studies with 14C-aloe emodin after oral administration to male and female rats. Pharmacology · PMID 8234417 · DOI |
Animal research animal |
Male and female rats | 14C-labelled aloe-emodin by mouth isolated compound 4.5 mg/kg Single dose |
20-30% in urine, the rest in faeces; quick conversion to rhein; maximum plasma at 1.5-3 h; blood half-life of radioactivity about 50 h Plasma maxima 248 (male) and 441 (female) ng equivalents/ml Methods, limits and fundingOutcomes: Absorption, distribution, metabolism, excretion Limitations: Animal study of the isolated compound. Read: abstract |
| Langmead 2004 Randomized, double-blind, placebo-controlled trial of oral aloe vera gel for active ulcerative colitis. Aliment Pharmacol Ther · PMID 15043514 · DOI |
Controlled trial |
44 Outpatients with mild-to-moderate active ulcerative colitis (44 evaluable) |
Oral Aloe vera gel inner-leaf gel 100 mL twice daily 4 weeks · vs Placebo (2:1 randomization) |
Higher response rate; histology and clinical score fell; sigmoidoscopy and labs unchanged Response 47% vs 14% (OR 5.3); remission 30% vs 7% (OR 5.6, P = 0.09) (Response 1.0 to 27; remission 0.6 to 49) Methods, limits and fundingOutcomes: Clinical, sigmoidoscopic and histological remission; SCCAI; labs Limitations: Small single-centre trial; abstract only. Read: abstract |
| Lee 2004 Possible interaction between sevoflurane and Aloe vera. Ann Pharmacother · PMID 15292490 · DOI |
Case report |
1 35-year-old woman having surgery on a hemangioma |
Oral aloe vera tablets with sevoflurane anaesthesia |
Lost 5 litres of blood; interaction rated possible n/a Methods, limits and fundingOutcomes: Intraoperative blood loss Limitations: Single case; tumour vascularity the most important factor per the authors. Read: abstract |
| Maenthaisong 2007 The efficacy of aloe vera used for burn wound healing: a systematic review. Burns · PMID 17499928 · DOI |
Systematic review |
371 Burn wound patients, 4 studies |
Topical Aloe vera Varied Varied · vs Controls |
Aloe group healed sooner Summary weighted mean difference 8.79 days shorter (P = 0.006) Methods, limits and fundingOutcomes: Duration of wound healing Limitations: Searched to June 2004. Authors say products and outcome measures differ so a specific conclusion is not possible. Read: abstract |
| Najafian 2019 Efficacy of Aloe vera/ Plantago Major Gel in Diabetic Foot Ulcer: A Randomized Double-Blind Clinical Trial. Curr Drug Discov Technol · PMID 29336265 · DOI |
Controlled trial |
40 Patients with diabetic foot ulcers |
Plantavera gel (Aloe vera plus Plantago major) combination Twice daily 4 weeks · vs Placebo gel |
Total score and surface improved; depth did not P < 0.001 total; P = 0.039 surface; P = 0.263 depth Methods, limits and fundingOutcomes: Ulcer score, surface, depth Limitations: Combination product so effect cannot be assigned to aloe. Abstract only. Read: abstract |
| Nascimbeni 2002 Constipation, anthranoid laxatives, melanosis coli, and colon cancer: a risk assessment using aberrant crypt foci. Cancer Epidemiol Biomarkers Prev · PMID 12163329 |
Observational |
192 55 sigmoid cancer, 41 diverticular disease, 96 controls |
Anthranoid laxatives (not aloe-specific) various |
Did not support a cause-effect link n/a Methods, limits and fundingOutcomes: Aberrant crypt foci, melanosis coli Limitations: Small; anthranoid laxatives in general. Read: abstract |
| National Institute of Child Health and Human Development (database entry; updated 2024-11-15) 2024 Aloe (LactMed entry) Drugs and Lactation Database (LactMed) · PMID 30000889 |
Review |
Drugs and Lactation Database entry | Aloe gel and aloe latex gel; latex |
Latex should not be used while breastfeeding; gel can cause itching, burning, contact dermatitis n/a Methods, limits and fundingOutcomes: Safety in breastfeeding Limitations: Only the abstract of the entry was read. Read: abstract |
| National Institute of Diabetes and Digestive and Kidney Diseases (database entry; updated 2022-05-24) 2022 Aloe Vera (LiverTox entry) LiverTox: Clinical and Research Information on Drug-Induced Liver Injury · PMID 31643946 |
Review |
Drug-induced liver injury database entry | Oral aloe vera |
Oral forms linked to rare instances of clinically apparent liver injury n/a Methods, limits and fundingOutcomes: Liver injury Limitations: Only the abstract of the LiverTox chapter was read; case counts and likelihood score not read. Read: abstract |
| Nusko 2000 Anthranoid laxative use is not a risk factor for colorectal neoplasia: results of a prospective case control study. Gut · PMID 10764708 · DOI |
Observational |
554 202 colorectal cancer, 114 adenoma and 238 control patients |
Anthranoid laxatives (not aloe-specific) various |
No significant risk OR 1.0 (adenomas); OR 1.0 (carcinomas) (0.5 to 1.9; 0.6 to 1.8) Methods, limits and fundingOutcomes: Colorectal neoplasia Limitations: Case-control; anthranoid laxatives in general. Read: abstract |
| Odes 1991 A double-blind trial of a celandin, aloevera and psyllium laxative preparation in adult patients with constipation. Digestion · PMID 1800188 · DOI |
Controlled trial |
35 Adults with chronic constipation |
Capsule combining celandine, aloe vera and psyllium combination Not given in abstract 28 days · vs Placebo |
More frequent bowel movements, softer stools, less laxative dependence; abdominal pain unchanged No numbers in abstract Methods, limits and fundingOutcomes: Bowel movement frequency, stool consistency, laxative dependence, abdominal pain Limitations: Combination product; cannot assign effect to aloe; abstract only. Read: abstract |
| Panahi 2015 Efficacy and safety of Aloe vera syrup for the treatment of gastroesophageal reflux disease: a pilot randomized positive-controlled trial. J Tradit Chin Med · PMID 26742306 · DOI |
Controlled trial |
79 People with gastroesophageal reflux disease |
Aloe vera syrup (5.0 mg polysaccharide per mL) 10 mL a day 4 weeks · vs Omeprazole 20 mg or ranitidine 150 mg (no placebo) |
Reduced frequency of all assessed symptoms; no adverse events needing withdrawal No numbers in abstract Methods, limits and fundingOutcomes: Frequency of eight GERD symptoms Limitations: Pilot, no placebo; abstract only. Read: abstract |
| Paulsen 2005 A double-blind, placebo-controlled study of a commercial Aloe vera gel in the treatment of slight to moderate psoriasis vulgaris. J Eur Acad Dermatol Venereol · PMID 15857459 · DOI |
Controlled trial |
41 Adults with stable plaque psoriasis (40 analysed) |
Commercial preserved Aloe vera gel inner-leaf gel (commercial) Twice daily 4 weeks · vs Placebo gel (right/left comparison) |
Placebo sites improved more; 55% reported local side effects, mainly dryness 72.5% of aloe sites vs 82.5% of placebo sites improved, P = 0.0197 Methods, limits and fundingOutcomes: Erythema, infiltration, desquamation score sum Limitations: Small; abstract only. Read: abstract |
| Puvabanditsin 2005 Efficacy of aloe vera cream in prevention and treatment of sunburn and suntan. J Med Assoc Thai · PMID 16623024 |
Controlled trial |
20 Volunteers exposed to UVB |
Aloe vera cream 70% cream Before and/or after UV, then twice daily for 3 weeks 3 weeks · vs Placebo |
No protection or treatment benefit No difference Methods, limits and fundingOutcomes: Minimal erythema dose; erythema; pigmentation Limitations: Small, old trial; abstract only. Read: abstract |
| Radha 2015 Evaluation of biological properties and clinical effectiveness of Aloe vera: A systematic review. J Tradit Complement Med · PMID 26151005 · DOI |
Narrative review |
Systematic review of aloe gel composition and effects | Aloe vera gel inner-leaf gel |
Says more than 200 biologically active substances and more than 400 Aloe species; notes not much convincing information on gel properties n/a Methods, limits and fundingOutcomes: Composition and biological properties Limitations: Narrative review; abstract only. Read: abstract |
| Reddy 2012 Randomized trial of aloe vera gel vs triamcinolone acetonide ointment in the treatment of oral lichen planus. Quintessence Int · PMID 23041995 |
Controlled trial |
40 Patients with oral lichen planus (erosive and atrophic) |
Aloe vera gel gel Not given in abstract 8 weeks · vs Triamcinolone acetonide ointment |
Aloe gel more effective than triamcinolone No numbers in abstract Methods, limits and fundingOutcomes: Clinical signs and symptoms Limitations: Small; abstract only; one centre. Read: abstract |
| Reider 2005 Absence of contact sensitization to Aloe vera (L.) Burm. f. Contact Dermatitis · PMID 16364121 · DOI |
Observational |
702 Consecutive patch-test patients |
Aloe oily leaf extract, aloe pulvis (whole plant), concentrated aloe vera gel leaf extract; whole plant powder; gel Patch test |
No reaction to any preparation 0 of 702 Methods, limits and fundingOutcomes: Contact sensitization Limitations: Patch test of preparations as tested; the authors note the gel is mainly carbohydrate. Abstract only. Read: abstract |
| Richardson 2005 Aloe vera for preventing radiation-induced skin reactions: a systematic literature review. Clin Oncol (R Coll Radiol) · PMID 16149293 · DOI |
Systematic review |
Cancer patients having radiotherapy; 5 published and 2 unpublished RCTs | Aloe vera gel gel Varied Varied · vs Controls |
No evidence of benefit No effect Methods, limits and fundingOutcomes: Radiation skin reactions Limitations: Searched to about 2004. Abstract only. Read: abstract |
| Sadgrove 2021 Pharmacodynamics of Aloe vera and acemannan in therapeutic applications for skin, digestion, and immunomodulation. Phytother Res · PMID 34427371 · DOI |
Narrative review in-vitro |
Review of aloe vera and acemannan pharmacodynamics | Aloe vera and acemannan inner-leaf gel |
Describes proposed mechanisms; notes contradictory results and that more research is needed n/a Methods, limits and fundingOutcomes: Mechanisms for skin, digestion and immunomodulation Limitations: Narrative review; abstract only. Read: abstract |
| Sahebnasagh 2022 Aloe vera for Prevention of Acute Radiation Proctitis in Colorectal Cancer a Preliminary Randomized, Placebo-Controlled Clinical Trial. J Gastrointest Cancer · PMID 33616843 · DOI |
Controlled trial |
20 Colorectal cancer patients having radiotherapy |
3% Aloe vera ointment ointment (plant part not stated) 1 g twice daily 6 weeks · vs Placebo ointment |
Diarrhoea, quality of life, depression score and CRP improved; toxicity grading not significantly different Diarrhoea P = 0.029 Methods, limits and fundingOutcomes: Radiation proctitis, quality of life, HAD scale, CRP Limitations: Very small preliminary trial. Abstract only. Read: abstract |
| Sharma 2022 Second-Degree Burns and Aloe Vera: A Meta-analysis and Systematic Review. Adv Skin Wound Care · PMID 36264753 · DOI |
Meta-analysis |
133 Second-degree burn patients (4 studies; 163 wounds); wider systematic review of 28 RCTs |
Topical Aloe vera Varied Varied · vs Other treatments |
Faster healing with aloe Mean difference 4.44 days in favour of aloe (P = .004) Methods, limits and fundingOutcomes: Time to healing Limitations: Abstract only; meta-analysis limited to 4 burn studies; risk-of-bias results not given in abstract. Read: abstract |
| Suksomboon 2016 Effect of Aloe vera on glycaemic control in prediabetes and type 2 diabetes: a systematic review and meta-analysis. J Clin Pharm Ther · PMID 27009750 · DOI |
Meta-analysis |
470 Adults with prediabetes (235) or type 2 diabetes (235); 8 RCTs |
Oral Aloe vera Varied Varied · vs Placebo/control |
Lower FPG in prediabetes; HbA1c lower in type 2 diabetes Prediabetes FPG -0.22 mmol/L; T2D HbA1c -11 mmol/mol (FPG -0.32 to -0.12; HbA1c -19 to -2) Methods, limits and fundingOutcomes: Fasting plasma glucose; HbA1c Limitations: High heterogeneity; authors call for standardized preparations. Abstract only. Read: abstract |
| Syed 1996 Management of psoriasis with Aloe vera extract in a hydrophilic cream: a placebo-controlled, double-blind study. Trop Med Int Health · PMID 8765459 · DOI |
Controlled trial |
60 Adults 18-50 with mild-to-moderate plaque psoriasis |
0.5% Aloe vera extract in hydrophilic cream extract (part not stated) 3 times daily, 5 days a week Up to 4 weeks active treatment, 16-week study, 12-month follow-up · vs Placebo cream |
25/30 cured vs 2/30 83.3% vs 6.6% cured (P < 0.001); plaques cleared 82.8% vs 7.7% Methods, limits and fundingOutcomes: Cure rate, plaques cleared, PASI Limitations: The effect is far larger than in two later trials; outcomes defined by the authors; not independently repeated in the studies read. Abstract only. Read: abstract |
| Thunyakitpisal 2017 Acemannan increases NF-κB/DNA binding and IL-6/-8 expression by selectively binding Toll-like receptor-5 in human gingival fibroblasts. Carbohydr Polym · PMID 28189222 · DOI |
Laboratory research in-vitro |
Human gingival fibroblasts; computer modelling | Acemannan inner-leaf gel In cell culture · vs Untreated cells; blocking antibody |
Raised IL-6/-8 and p50 binding; blocked by anti-TLR5 antibody Significant increases (P not given) Methods, limits and fundingOutcomes: IL-6, IL-8, NF-kB DNA binding Limitations: Cell and computer study. Read: abstract |
| Tungkasamit 2022 Reduction in severity of radiation-induced dermatitis in head and neck cancer patients treated with topical aloe vera gel: A randomized multicenter double-blind placebo-controlled trial. Eur J Oncol Nurs · PMID 35767935 · DOI |
Controlled trial |
120 Head and neck cancer patients on concurrent chemoradiation |
Aloe vera gel gel Not given in abstract 8 weeks of CCRT · vs Placebo gel |
Median scores not different; less moderate-severe erythema (weeks 5 and 6) and moist desquamation (week 7) with aloe; authors state no prophylactic efficacy Erythema 13.6% vs 27.8% (wk 5), 24.1% vs 42.6% (wk 6); moist desquamation 19.0% in placebo wk 7 Methods, limits and fundingOutcomes: RISRAS skin reaction score Limitations: Secondary findings; main score null. Abstract only. Read: abstract |
| Williams 1996 Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity. Int J Radiat Oncol Biol Phys · PMID 8892458 · DOI |
Controlled trial |
302 Women having breast or chest wall radiotherapy (two trials: 194 and 108) |
Aloe vera gel gel Not given in abstract During radiotherapy · vs Placebo gel (194); no treatment (108) |
Virtually identical on both arms; rare contact dermatitis from the gel No difference Methods, limits and fundingOutcomes: Weekly dermatitis scores Limitations: Old trial; abstract only. n = 194 + 108. Funding and conflicts: Public health service research support listed Read: abstract |
| Xie 2025 CLINICAL EFFECT OF LOCAL ALOE VERA USE AS AN ADJUNCT TO PERIODONTAL THERAPY: A SYSTEMATIC REVIEW AND META-ANALYSIS. J Evid Based Dent Pract · PMID 41290277 · DOI |
Meta-analysis |
Adults with periodontitis; 3 RCTs | Aloe vera gel placed in gum pockets with scaling and root planing gel Local, varied 3 to 12 months · vs Scaling and root planing alone or placebo |
Small gains in PPD and CAL PPD MD -0.47 mm (3 months); CAL MD -0.98 (12 months) (PPD -0.78 to -0.16; CAL -1.28 to -0.68) Methods, limits and fundingOutcomes: Probing pocket depth, clinical attachment level, plaque, bleeding Limitations: Authors say evidence not reliable enough for clinical advice. Abstract only. Registration: PROSPERO CRD42022336946 Read: abstract |
| Yang 2010 Aloe-induced toxic hepatitis. J Korean Med Sci · PMID 20191055 · DOI |
Case report |
3 Three women aged 57, 62 and 55 with toxic hepatitis |
Oral aloe preparations Months |
RUCAM criteria met; enzymes normalised after stopping n/a Methods, limits and fundingOutcomes: Liver enzymes, histology Limitations: Three cases; product not described in abstract. Read: abstract |
| Yun 2010 A randomized placebo-controlled crossover trial of aloe vera on bioavailability of vitamins C and B(12), blood glucose, and lipid profile in healthy human subjects. J Diet Suppl · PMID 22435613 · DOI |
Controlled trial |
15 Healthy adult volunteers, crossover |
Aloe inner-leaf (fillet) gel and aloe whole-leaf decolorized gel, with vitamin C 500 mg and B12 1 mg inner-leaf gel; whole leaf (decolorized) Single dose 24 hours · vs Water with vitamins |
Higher vitamin C and B12 and antioxidant capacity P < 0.01 at stated times Methods, limits and fundingOutcomes: Plasma vitamins C and B12, ORAC, glucose, lipids Limitations: Small; lipid and glucose results not in abstract; abstract only. Funding and conflicts: Research support from NIH extramural listed Read: abstract |
| Zhang 1996 Activation of a mouse macrophage cell line by acemannan: the major carbohydrate fraction from Aloe vera gel. Immunopharmacology · PMID 8956975 · DOI |
Laboratory research in-vitro |
Mouse macrophage cell line RAW 264.7 | Acemannan (major carbohydrate fraction of Aloe vera gel) inner-leaf gel Dose-dependent In cell culture · vs Untreated cells; interferon-gamma combination |
Acemannan stimulated cytokine production, nitric oxide and surface marker changes IL-6 and TNF-alpha dose-dependent Methods, limits and fundingOutcomes: Cytokines, nitric oxide, surface molecules, cell shape Limitations: Lab study in mouse cells. Read: abstract |
| s-ema-hmpc-aloe-2016 EMA/HMPC European Union herbal monograph on Aloe barbadensis Mill. and on Aloe (various species, mainly Aloe ferox Mill. and its hybrids), folii succus siccatus (EMA/HMPC/625788/2015, adopted 22 November 2016) · Source |
Authoritative guidance n/a |
Methods, limits and fundingRead: full-text | ||
| s-fda-2002-aloe-laxative US FDA 2002 final rule removing aloe and cascara sagrada from OTC laxative products (67 FR 31125) · Source |
Authoritative guidance n/a |
Methods, limits and fundingRead: summary-only | ||
| s-gbif-aloe-vera GBIF Backbone Taxonomy: Aloe vera (L.) Burm.f. (usageKey 2777724) · Source |
Reference database n/a |
Methods, limits and fundingRead: full-text | ||
| s-iarc-108-aloe IARC Monographs vol. 108: Some Drugs and Herbal Products (2016), Aloe vera section, pp. 37-71 · Source |
Authoritative guidance n/a |
Methods, limits and fundingRead: summary-only | ||
| s-ncbi-taxonomy-aloe-vera NCBI Taxonomy: Aloe vera (taxid 34199) · Source |
Reference database n/a |
Methods, limits and fundingRead: full-text | ||
| s-nccih-aloe-vera NCCIH: Aloe Vera - Usefulness and Safety (page last updated February 2025) · Source |
Authoritative guidance n/a |
Methods, limits and fundingRead: full-text | ||
| s-oehha-prop65-aloe OEHHA Proposition 65 Warnings fact sheet: Aloe Vera, Non-decolorized Whole Leaf Extract (November 2020) · Source |
Authoritative guidance n/a |
Methods, limits and fundingRead: full-text |
What we do not know yet
- What the evidence supports: nothing is rated above low. Minor burns, acne with tretinoin, oral lichen planus, oral submucous fibrosis, oral mucositis, gum inflammation, blood sugar, weight, irritable bowel syndrome, ulcerative colitis and the latex laxative are low; wounds beyond burns, radiation bowel irritation, gum pockets, acid reflux and vitamin levels are very low; psoriasis and radiotherapy skin reactions are mixed; blood fats are insufficient; sunburn is against.
- What is uncertain: most trials are small and short, use different aloe products and often do not say whether they used gel, whole-leaf extract or something containing latex. Reviews of burns disagree with the older Cochrane review, and the blood sugar reviews show heterogeneity and publication bias.
- What has never been tested: aloe gel against modern burn dressings in large trials; long-term safety of oral gel; aloe with warfarin, diabetes medicines or heart medicines; safety in children and pregnancy; and whether decolorized whole-leaf extract raises cancer risk in people.
- What we could not verify: the full LiverTox chapter (only the abstract was read), the IARC monograph and the FDA 2002 laxative rule (known only through NCCIH and a review abstract), the German Commission E and WHO monographs, and a food-nutrient table. Cancer evidence is from rats for the non-decolorized extract.
- Only abstracts were read for nearly all studies, and funding was rarely stated in them. The NCCIH page was read through a page-summary tool.
How new research is added
New studies are found by a saved PubMed search and are placed in a review queue. A person reads each one before it changes any evidence rating or safety wording. New publications never change ratings automatically.
Lab markers
What changed in blood or saliva tests during trials. A changed number is not the same as feeling or being healthier, and we give no "normal ranges".
Metabolic 4
Fasting blood glucose
Lowered in trials
Blood sugar after an overnight fast.
Low certaintyResults and what it means
Why it was measured
Main outcome of diabetes and prediabetes trials.
Statistical vs. clinical meaning
Statistical drops of varying size; marginal in type 2 diabetes in one review.
Safety implication
May add to diabetes medicines.
| Study | Result | People | Product |
|---|---|---|---|
| 50 | Prediabetes MD -0.22 mmol/L (95% CI -0.32 to -0.12); type 2 diabetes MD -1.17 mmol/L (95% CI -2.35 to 0.00) | 8 RCTs, 470 patients | Oral aloe vera |
| 16 | -46.6 mg/dL (p < 0.0001); publication bias shown | 9 studies, n = 283 | Oral aloe vera |
| 10 | Between-group difference not significant at 8 weeks (P = 0.16) | 136 obese adults with prediabetes or early diabetes | Aloe QDM complex |
HbA1c (3-month blood sugar average)
Lowered in trials
Share of haemoglobin carrying sugar; reflects average blood sugar over about 3 months.
Low certaintyResults and what it means
Why it was measured
Standard long-term diabetes control marker.
Statistical vs. clinical meaning
Bigger than expected from lab work, but trials small and uneven; a lower HbA1c is not the same as fewer complications.
Safety implication
None.
Fasting insulin and insulin resistance (HOMA-IR)
Lowered in trials
Blood insulin and a calculation of how resistant the body is to it.
Low certaintyResults and what it means
Why it was measured
Insulin resistance marker.
Statistical vs. clinical meaning
Borderline and not sustained at 8 weeks.
Safety implication
None.
| Study | Result | People | Product |
|---|---|---|---|
| 10 | Insulin P = 0.04 and HOMA-IR P = 0.047 lower at 4 weeks; borderline at 8 weeks (P = 0.09 and 0.08) | 136 obese adults | Aloe QDM complex |
Triglycerides
Mixed results in trials
A blood fat.
Not enough evidenceInflammatory 1
C-reactive protein (CRP)
Lowered in trials
A blood marker of inflammation.
Very low certaintyResults and what it means
Why it was measured
Inflammation marker in the proctitis trial.
Statistical vs. clinical meaning
A blood marker change is not proof of a clinical benefit; n = 20.
Safety implication
None.
| Study | Result | People | Product |
|---|---|---|---|
| 48 | Quantitative CRP decreased significantly during treatment with aloe | 20 colorectal cancer patients having radiotherapy | 3% aloe vera ointment vs placebo |
Other 11
Burn healing time (days)
Lowered in trials
Days until a burn wound is closed with new skin.
Low certaintyResults and what it means
Why it was measured
Main outcome of burn trials.
Statistical vs. clinical meaning
A few days faster; whether this matters depends on the burn. Pain and infection did not clearly differ.
Safety implication
Not for serious burns.
| Study | Result | People | Product |
|---|---|---|---|
| 23 | MD -3.76 days (95% CI -5.69 to -1.84), aloe vs other topicals | 9 RCTs, 6 with healing data, mainly second-degree burns | Aloe vera topical |
| 49 | 4.44 days faster, P = .004 | 4 trials, 133 patients, 163 wounds | Topical aloe vera |
| 33 | 8.79 days shorter, P = 0.006 | 4 studies, 371 patients | Topical aloe vera |
| 9 | Donor-site epithelialization 11.5 vs 13.67 days | 12 patients, 24 sites | Aloe vera gel vs placebo |
Psoriasis Area and Severity Index (PASI)
Mixed results in trials
A doctor's score of redness, thickness and scaling of psoriasis plaques.
Mixed findingsResults and what it means
Why it was measured
Standard psoriasis severity score.
Statistical vs. clinical meaning
Trials disagree, so the average hides opposite results.
Safety implication
Dryness was common in one trial.
| Study | Result | People | Product |
|---|---|---|---|
| 11 | PASI 11.6 to 3.9 (aloe) vs 10.9 to 4.3 (0.1% triamcinolone); between-group difference 1.1 (95% CI -2.13 to -0.16) | 80 adults, 8 weeks | Aloe vera cream vs steroid cream |
| 41 | Score sum fell in 72.5% of aloe sites vs 82.5% of placebo sites; P = 0.0197 favouring placebo | 40 analysed, right/left | Commercial aloe vera gel vs placebo |
| 51 | Cured 25/30 vs 2/30; PASI fell to a mean of 2.2 | 60 adults | 0.5% aloe vera extract cream vs placebo |
| 19 | PASI SMD -1.32 (95% CI -1.86 to -0.78) in two studies | Meta-analysis, adults | Aloe vera gel |
Radiation skin reaction score
No clear change in trials
A clinician or patient rating of redness, peeling and burning of skin treated with radiotherapy (for example RISRAS).
Mixed findingsResults and what it means
Why it was measured
Main outcome in radiotherapy skin trials.
Statistical vs. clinical meaning
The main scores did not change; some secondary findings favoured aloe.
Safety implication
Rare contact dermatitis.
| Study | Result | People | Product |
|---|---|---|---|
| 54 | Skin dermatitis scores 'virtually identical' in two phase III trials | 194 + 108 women, breast or chest wall radiotherapy | Aloe vera gel vs placebo gel or no treatment |
| 53 | Median RISRAS not different weeks 1 to 8; moderate-severe erythema 13.6% vs 27.8% (wk 5) and 24.1% vs 42.6% (wk 6) | 120 head and neck cancer patients | Aloe vera gel vs placebo gel |
Mouth pain or burning (visual analogue scale)
Mixed results in trials
A patient rating of pain or burning on a 0 to 10 or 0 to 100 line.
Low certaintyResults and what it means
Why it was measured
Main symptom in oral submucous fibrosis and lichen planus.
Statistical vs. clinical meaning
Relief fades by 3 months in one analysis and was not significant across skin and mucosa trials.
Safety implication
None specific.
Severe oral mucositis (grade 3 and 4)
Lowered in trials
The number of people with severe mouth sores during cancer treatment.
Low certaintyResults and what it means
Why it was measured
Main clinical outcome in mucositis trials.
Statistical vs. clinical meaning
Fewer severe cases versus placebo only.
Safety implication
None specific.
| Study | Result | People | Product |
|---|---|---|---|
| 12 | OR 0.32 (95% CI 0.15 to 0.70) overall; OR 0.22 (95% CI 0.11 to 0.44) vs placebo; no difference vs sodium bicarbonate or benzydamine | 7 RCTs, 355 people | Aloe vera mouth preparations |
Probing pocket depth and clinical attachment level (gum disease)
Lowered in trials
Depth of the gum pocket around a tooth, and how much the gum has lost attachment, in millimetres.
Very low certaintyResults and what it means
Why it was measured
Standard dental measures of gum disease.
Statistical vs. clinical meaning
Statistically significant but the authors say the evidence is not reliable enough for advice.
Safety implication
None.
| Study | Result | People | Product |
|---|---|---|---|
| 55 | PPD MD -0.47 mm at 3 months (95% CI -0.78 to -0.16); CAL MD -0.98 at 12 months (95% CI -1.28 to -0.68) | 3 RCTs, adults with periodontitis | Aloe vera gel as an add-on to scaling and root planing |
Acne lesion scores
Lowered in trials
Counts or scores of inflammatory and non-inflammatory pimples.
Low certaintyResults and what it means
Why it was measured
Main outcome in acne trials.
Statistical vs. clinical meaning
One small trial; actual counts not given in the abstract.
Safety implication
Scaling was the most common effect.
| Study | Result | People | Product |
|---|---|---|---|
| 21 | Non-inflammatory P = 0.001; inflammatory P = 0.011; total P = 0.003 vs tretinoin plus vehicle | 60 people, 8 weeks | 50% aloe vera gel plus 0.05% tretinoin |
Body weight and body fat mass
Lowered in trials
Weight and fat mass, measured by scale and body composition test.
Low certaintyResults and what it means
Why it was measured
Outcome in the obesity trial.
Statistical vs. clinical meaning
One trial; clinical size unknown.
Safety implication
None.
| Study | Result | People | Product |
|---|---|---|---|
| 10 | Weight P = 0.02, fat mass P = 0.03 lower at 8 weeks; amounts not given in abstract | 136 obese adults with prediabetes or early diabetes | Aloe QDM complex (aloe vera gel complex) |
IBS symptom score
Lowered in trials
Patient-rated severity of IBS symptoms.
Low certaintyResults and what it means
Why it was measured
Main outcome in IBS trials.
Statistical vs. clinical meaning
Small effect, wide interval.
Safety implication
No aloe-related adverse events in the included studies.
| Study | Result | People | Product |
|---|---|---|---|
| 22 | SMD 0.41 (95% CI 0.07 to 0.75); response RR 1.69 (95% CI 1.05 to 2.73) | 3 RCTs, 151 people | Oral aloe vera vs placebo |
Colitis activity (Simple Clinical Colitis Activity Index and histology)
Mixed results in trials
A symptom score and a biopsy score of ulcerative colitis activity.
Low certaintyResults and what it means
Why it was measured
Outcomes in the ulcerative colitis trial.
Statistical vs. clinical meaning
Some scores improved, endoscopy did not.
Safety implication
Adverse events minor and similar to placebo.
| Study | Result | People | Product |
|---|---|---|---|
| 31 | Clinical and histological scores fell with aloe (P = 0.01 and 0.03) but not with placebo; sigmoidoscopic scores and lab markers no significant difference | 44 evaluable patients | Oral aloe vera gel 4 weeks |
Plasma vitamin C and vitamin B12
Raised in trials
Blood levels of vitamins C and B12 after a dose.
Very low certaintyResults and what it means
Why it was measured
Absorption test in the crossover trial.
Statistical vs. clinical meaning
Short-term blood levels only.
Safety implication
None.
| Study | Result | People | Product |
|---|---|---|---|
| 57 | Vitamin C higher at 4, 6, 8, 24 h (gel) and 4, 6 h (whole-leaf); B12 higher at 1 and 2 h (both); P < 0.01 | 15 healthy adults | Aloe gel or whole-leaf decolorized aloe with vitamins C and B12 |
Safety
What studies and official sources say about side effects, medicines and who should check first. Each point shows what kind of evidence it comes from.
Main points to know 8
- Aloe vera is three different products: only the clear inner-leaf gel is the 'gentle' one. The clear gel from the middle of the leaf is used on skin and sold as juice. The bitter yellow latex just under the leaf skin contains aloin and other anthraquinones that act as a strong stimulant laxative. Whole-leaf extracts can contain both. A 'decolorized' whole-leaf extract has the anthraquinones filtered out; a 'non-decolorized' one does not. Most safety problems below belong to the latex and the non-decolorized whole-leaf extract, not to the gel. Product labels do not always say which one you are buying, so check the label or ask the maker. Authoritative guidance 36 64 65 20
- Aloe latex and aloin are strong laxatives that can cause cramps, diarrhoea and potassium loss. The EU monograph on aloe dried leaf juice limits it to occasional constipation, for no more than one week, and contraindicates it in pregnancy, breastfeeding, children under 12, bowel blockage, inflammatory bowel disease, abdominal pain of unknown cause and severe dehydration. Long use can cause dependence, loss of water and salts, and urine changes. The US FDA required aloe latex to be taken out of over-the-counter laxatives in 2002 because of a lack of safety data (as reported by NCCIH). Authoritative guidance 59 64 60
- Non-decolorized whole-leaf extract caused bowel cancers in rats and is rated 'possibly carcinogenic to humans'. In a two-year US National Toxicology Program study, rats given non-decolorized whole-leaf extract in their drinking water developed large-intestine cancers that were not seen in controls, and both rats and mice developed bowel overgrowth (hyperplasia). The International Agency for Research on Cancer classified this extract as possibly carcinogenic to humans (Group 2B) based on animal evidence, and California lists it under Proposition 65. This is animal evidence on one type of extract. Human studies of related anthranoid laxatives did not find a higher colorectal cancer risk, but they were not about aloe and are older. Decolorized extracts have the anthraquinones removed and are not the material that was classified. Animal research 8 62 65 20 38 35 29
- Oral aloe products have been linked to liver injury. LiverTox says oral forms of aloe vera have been linked to rare instances of clinically apparent liver injury. Published case reports describe acute hepatitis in people who took oral aloe capsules or preparations for weeks to months, with liver tests returning to normal after stopping. NCCIH says leaf extracts used for as little as 3 weeks and as long as 5 years have been linked to acute hepatitis. The products in the reports were not always described, so we cannot tell if gel, latex or whole-leaf extract was responsible. Stop and get care for yellow skin or eyes, dark urine or pale stools. Case report 37 6 56 64 59
- Do not use aloe latex or oral laxative aloe in pregnancy or while breastfeeding. The EU monograph contraindicates aloe dried juice in pregnancy because several anthranoids (including emodin and aloe-emodin) showed genotoxic risk in experiments, and in breastfeeding because related anthranoid metabolites pass into breast milk in small amounts. NCCIH says oral aloe in gel, latex or whole-leaf form may be unsafe in pregnancy and breastfeeding. LactMed says aloe latex should not be used while breastfeeding; aloe gel on the nipples should be washed off before feeding because the taste may upset the baby or cause diarrhoea. Authoritative guidance 59 64 36
- Kidney disease, heart rhythm medicines and diuretics need extra care with aloe latex. The EU monograph says long use can cause water and salt imbalance, and albuminuria and haematuria; people with kidney disorders should be aware of electrolyte imbalance. Low potassium from laxative use can strengthen the effect of heart medicines such as digoxin and affects heart rhythm drugs; diuretics, steroids and liquorice can add to potassium loss. NCCIH also warns about aloe latex and digoxin-type drugs. Ask a doctor or pharmacist before using aloe latex with any of these. Authoritative guidance 59 64 20
- Tell the surgical team if you take oral aloe before an operation. One case report links oral aloe vera tablets and the anaesthetic sevoflurane to heavy bleeding during surgery. That is a single report of a possible interaction, so it does not show cause. It is a reason to mention aloe to your surgeon and anaesthetist. Case report 32
- Aloe gel on the skin can cause irritation or allergy in some people. Aloe gel is usually well tolerated. NCCIH reports occasional burning, itching, rash and eczema. A trial in breast radiotherapy found rare contact dermatitis from the gel, one case report documents allergic contact dermatitis to home-made leaf juice, and a patch-test study of 702 patients found no sensitization. Irritation may sometimes come from latex contamination of the gel. Stop use if you get a rash. Case report 64 54 18 45 36
Side effects 9
| Effect | How often | Severity and recovery | Evidence |
|---|---|---|---|
| Abdominal pain, cramps and loose stools or diarrhoea (aloe latex / dried leaf juice) The EU monograph says frequencies are not known. These effects belong to the anthraquinones in latex, not to aloe gel. | Not established | mild to moderate; severe diarrhoea with overdose Usually settles after stopping or lowering the amount | Authoritative guidance 59 64 |
| Loss of water and salts, especially potassium, with long or excessive use of aloe latex Reviews also list diarrhoea, hypokalaemia and kidney dysfunction with ingestion of aloe products. | Not established | moderate to serious, especially in older people Reversible with fluids and electrolytes if caught | Authoritative guidance 59 7 20 |
| Dependence on laxatives and weakened bowel function with long use EMA says long-term use of stimulant laxatives should be avoided. | Not established | moderate Not stated | Authoritative guidance 59 |
| Dark colouring of the bowel lining (pseudomelanosis coli) Not a cancer sign by itself; see the colorectal cancer discussion in toxicity. | Not established | mild; no symptoms Usually recedes after stopping (EMA) | Authoritative guidance 59 20 |
| Protein or blood in the urine with long use; yellow or red-brown urine colour From the EU monograph on aloe dried leaf juice. | Not established | urine colour not clinically significant; albuminuria and haematuria need a doctor Not stated | Authoritative guidance 59 |
| Liver inflammation (acute hepatitis) with oral aloe products LiverTox calls it rare; no frequency figure is given. | Not established | moderate to serious Liver tests returned to normal after stopping in the case reports read | Case report 37 6 56 |
| Skin dryness, burning, itching, rash or contact dermatitis from aloe on the skin The cause may be latex contamination of the gel (LactMed). | In one psoriasis trial 55% reported local side effects, mainly dryness (Paulsen 2005); rare contact dermatitis in radiotherapy trials (Williams 1996) | mild Settles after stopping | Controlled trial 41 54 64 36 |
| Delayed healing of an open surgical wound One trial in the Cochrane review found aloe significantly delayed healing of surgical wounds healing from the bottom up (mean 30 days). | Not established | moderate Not stated | Systematic review 13 |
| Oral aloe gel in trials: minor adverse events similar to placebo Short trials of 4 weeks or so. | Minor and similar in both groups (ulcerative colitis trial); none related to aloe in the IBS trials pooled | mild Not stated | Controlled trial 31 22 |
Liver
LiverTox says oral forms of aloe vera have been linked to rare instances of clinically apparent liver injury. We read two published reports: a 73-year-old woman admitted with acute hepatitis after using oral aloe vera capsules for constipation, whose liver markers returned to normal after she stopped (causality rated possible on the Naranjo scale and probable on RUCAM; the authors used the more cautious label), and three Korean women (55 to 62 years) who took aloe preparations for months and had toxic hepatitis by RUCAM, with liver enzymes returning to normal after stopping. NCCIH says oral leaf extracts used for as little as 3 weeks and as long as 5 years have been linked to acute hepatitis. The EU monograph also warns that chronic overdose of anthranoid-containing medicines may lead to toxic hepatitis. None of the sources read says which part of the plant or which product caused the injury. 37 6 56 64 59
How often. No frequency was found. LiverTox calls the injury rare. The case reports show that injury can happen, not how often. The LiverTox likelihood score was not read.
Monitoring. No agency monitoring advice was read. Stop and seek care for yellow skin or eyes, dark urine, pale stools, right-upper belly pain, or marked tiredness; tell your doctor about all herbal products.
- .
- .
This is a safety connection. It is not evidence that Aloe Vera supports liver health.
Medicines and supplements 7
| With | Why it matters | Importance | Evidence | What to do |
|---|---|---|---|---|
| Digoxin and other cardiac glycosides; heart rhythm (antiarrhythmic) drugs; drugs that prolong the QT interval prescription | Laxative-induced potassium loss (low potassium) strengthens the effect of cardiac glycosides and interacts with antiarrhythmic drugs. | The EU monograph on aloe dried leaf juice says patients on these drugs must consult a doctor before taking aloe. NCCIH says overuse of aloe latex may increase side effects of cardiac glycosides such as digoxin. This applies to latex-type products, not to aloe gel on skin. | Authoritative guidance Low certainty 59 64 | Do not use aloe latex or laxative aloe with these medicines unless your doctor agrees. |
| Diuretics (water pills), corticosteroids by mouth, and liquorice root prescription and herbal | Each can lower potassium, adding to the loss caused by aloe latex. | The EU monograph says concomitant use may enhance potassium loss and requires a doctor's advice. No trial was read. | Authoritative guidance Low certainty 59 | Ask your doctor or pharmacist before using aloe latex with these. |
| Other stimulant laxatives (senna, cascara, bisacodyl and similar) over-the-counter | Same type of action, so effects and potassium loss add up. | No interaction study was read; this follows from how the products work. | Pharmacological theory Not enough evidence 59 | Do not combine laxatives without advice. |
| Diabetes medicines (insulin, metformin, sulfonylureas) prescription | Oral aloe lowered blood sugar in pooled trials, which could add to the medicine and cause low blood sugar. | Pooled analyses show glucose-lowering. No study read checked low blood sugar with aloe plus a diabetes drug. | Pharmacological theory Not enough evidence 50 16 | If you take diabetes medicine, tell your doctor before using oral aloe and watch your blood sugar. |
| Anaesthetics and blood thinners or antiplatelet drugs (for example sevoflurane) prescription | The case report authors suggest aloe may reduce prostaglandin production and platelet clumping, adding to the bleeding effect of the anaesthetic. | A single 35-year-old woman lost 5 litres of blood during surgery for a vascular tumour (hemangioma) after taking aloe tablets; the authors rated the interaction as possible and said the tumour was the main cause. | Case report Very low certainty 32 | Tell your surgeon and anaesthetist about any oral aloe before an operation. |
| Vitamins C and B12 taken together with aloe supplement | Blood levels of both vitamins were higher after aloe gel or decolorized whole-leaf aloe than after water. | 15 healthy adults in a crossover trial. This is an absorption finding rather than a harm; the meaning is unknown. | Controlled trial Very low certainty 57 | No action needed; mention supplements to your pharmacist. |
| Any prescription medicine (general) prescription | NCCIH advises talking to a health care provider before using aloe if you take any medicine. | Few formal interaction studies exist. | Authoritative guidance Low certainty 64 | Ask your pharmacist. |
Who should check first 9
| Situation | Advice | Evidence |
|---|---|---|
| Allergy to aloe or other plants in the same family, or past allergic reaction | Avoid. The EU monograph lists hypersensitivity as a contraindication, and allergic contact dermatitis to aloe leaf juice has been documented. | Authoritative guidance 59 18 |
| Pregnancy: oral aloe (latex, laxative dried juice, and oral gel or whole-leaf extract) | Avoid. The EU monograph contraindicates dried leaf juice in pregnancy; NCCIH says oral gel, latex and whole-leaf aloe may be unsafe. | Authoritative guidance 59 64 |
| Breastfeeding: oral aloe, aloe latex | Avoid latex (LactMed, EMA). If gel was put on the nipples, wash it off before feeding. | Authoritative guidance 36 59 |
| Children under 12: aloe dried leaf juice / laxative aloe | Contraindicated by the EU monograph. Safety of oral aloe gel in children was not found in the sources read. | Authoritative guidance 59 |
| Intestinal blockage or narrowing, appendicitis, inflammatory bowel disease (Crohn's disease, ulcerative colitis), abdominal pain of unknown cause, severe dehydration (for aloe laxative juice) | Do not use aloe laxatives. These are EU monograph contraindications. A small UC trial tested oral aloe gel, not latex; do not use either without your gastroenterologist. | Authoritative guidance 59 31 |
| Kidney disease | Take extra care with aloe laxatives because of electrolyte imbalance (EMA); reviews list kidney dysfunction with aloe ingestion. Ask your doctor. | Authoritative guidance 59 7 20 |
| Liver disease or a past liver reaction to aloe or herbal products | Avoid oral aloe products; case reports link them to hepatitis. | Case report 37 6 56 |
| Planned surgery or taking blood thinners | Tell your surgical team about oral aloe. | Case report 32 |
| Open, deep or infected wounds, or skin that is having radiotherapy | Ask a clinician before applying aloe. One trial found delayed healing of an open surgical wound; radiotherapy skin should only be treated as the cancer team directs. | Systematic review 13 54 |
Overdose, product quality and regulators
Summary. Aloe vera gel on skin is generally well tolerated, and oral gel up to about 42 days appeared safe in research studies (NCCIH). The main toxicity concerns are the latex anthraquinones (aloin and relatives), which are laxative and irritating, and the non-decolorized whole-leaf extract, which caused bowel cancers in rats. Reviews also link ingestion of aloe preparations to diarrhoea, low potassium, pseudomelanosis coli, kidney problems and liver injury.
Animal. US National Toxicology Program (Boudreau 2013, TR-577): groups of 48 rats received a non-decolorized whole-leaf extract of Aloe barbadensis Miller in drinking water at 0.5, 1 or 1.5% for 2 years, and mice at 1, 2 or 3%. Large-intestine hyperplasia rose markedly in all treated groups; rats also had small-intestine, stomach and lymph node hyperplasia; and large-intestine cancers appeared in male and female rats given the extract but none in control rats of this and other studies at the laboratory. Mice had large-intestine and lymph node or stomach hyperplasia. The EU monograph adds that emodin, a constituent of aloe dried juice, affected oestrous cycle length in rats and caused kidney damage in mice, and that long-term studies reported effects on kidney and colon or caecum.
Human doses studied. Oral aloe vera gel at 100 mL twice daily for 4 weeks in a small ulcerative colitis trial had minor adverse events similar to placebo; an aloe syrup at 10 mL a day for 4 weeks in a reflux trial had no adverse events requiring withdrawal. NCCIH says short-term oral gel use up to 42 days appears safe in research studies. The EU monograph's laxative dose is expressed as 10 to 30 mg hydroxyanthracene derivatives (as aloin), once at night, for at most a week.
High dose or long term signals. Long use of aloe latex: dependence, water and electrolyte loss, albuminuria, haematuria, pseudomelanosis coli (EMA). Oral aloe extracts and capsules: acute hepatitis case reports over weeks to years (NCCIH, case reports). Reviews list kidney failure as an association with ingestion, but the underlying case reports were not read.
Overdose response. The EU monograph says the main symptoms of overdose or abuse are griping pain and severe diarrhoea with loss of fluid and electrolytes, treated with generous fluids and monitoring of potassium, especially in older people. Chronic overdose of anthranoid medicines may lead to toxic hepatitis.
Genotoxicity. The EU monograph says no preclinical tests were available for aqueous aloe extracts, and that several hydroxyanthracene derivatives were mutagenic and genotoxic in several in vitro test systems, not proven in vivo. NCCIH says lab research suggests even decolorized extract might damage DNA or chromosomes. A 2023 review of the literature (Kim) concluded drinkable inner-leaf gel and decolorized whole-leaf products with no more than 10 ppm aloin are not genotoxic; NCCIH cites it, and we did not check the authors' ties to the industry. Human data on anthranoid laxatives and colorectal cancer: a prospective case-control study (Nusko 2000; 202 cancers, 114 adenomas, 238 controls) found no raised risk (odds ratio 1.0), an Italian study (Nascimbeni 2002) did not support a link using early bowel lesions as a marker, and the Melbourne study (Kune 1993; 685 cases, 723 controls) found no association. These studies covered anthranoid laxatives in general, not aloe alone.
Toxic plant parts. The plant part used is the leaf. The clear inner gel is the main material for skin and drinks. The latex (bitter yellow juice from just under the skin) contains aloin and other anthraquinones and is the laxative material (LactMed, EMA). Whole-leaf extracts contain both unless filtered. Toxicity of roots, flowers or other aloe species was not reviewed here; aloe species other than A. vera (for example A. ferox) are used in the EU monograph and should not be assumed to behave the same.
The key quality issue is how much aloin (latex anthraquinone) a product contains, which depends on how the leaves were processed. We found no survey of heavy metals, pesticides or adulteration in aloe supplements.
Aloin content depends on processing. In Greek aloe vera leaf gel products (Kaparakou 2021), samples processed industrially or filtered in the lab had aloin below the limit of 0.1 mg per litre that the paper cites for EU legislation, but unprocessed and unfiltered samples contained more than 10 mg per litre. 27
Decolorized vs non-decolorized whole-leaf extract. OEHHA states that most consumer products contain decolorized whole-leaf extract (filtered to remove cancer-causing chemicals), that a few contain the non-decolorized extract, and that labels do not always make this clear. NCCIH notes that the decolorized form has toxic anthraquinones removed. 65 64
Home-made leaf juice. OEHHA advises that if you make remedies from whole leaves, the plant's harmful chemicals should be removed, for example by filtering through an activated charcoal filter; a case report describes allergic contact dermatitis from home-made aloe leaf juice on the legs. 65 18
Supplements in general. LactMed warns that supplements can differ from their labels and that results on one product may not apply to another. 36
| Body | Action | Date |
|---|---|---|
| European Medicines Agency, Committee on Herbal Medicinal Products (HMPC) (European Union) | EU herbal monograph (EMA/HMPC/625788/2015) on Aloe barbadensis Mill. and Aloe (mainly Aloe ferox) dried leaf juice: for short-term use in occasional constipation, adolescents over 12 and adults, not more than 1 week; contraindicated in pregnancy, lactation, children under 12, intestinal obstruction, inflammatory bowel disease and more; warns about potassium loss and interactions with cardiac glycosides, diuretics, steroids and liquorice. source | 2016-11-22 |
| US National Center for Complementary and Integrative Health (NCCIH) (United States) | Aloe vera consumer page: topical gel generally well tolerated; oral gel up to 42 days appears safe in studies; latex causes cramps and diarrhoea; FDA required latex removal from OTC laxatives in 2002; oral leaf extracts linked to acute hepatitis; IARC classes non-decolorized whole leaf extract as possible human carcinogen; oral aloe may be unsafe in pregnancy and breastfeeding. source | 2025-02 |
| US National Toxicology Program (NTP) (United States) | Technical Report 577: nondecolorized whole leaf extract of Aloe barbadensis Miller in drinking water caused large-intestine cancers in rats and hyperplasia of the large intestine in rats and mice. source | 2013-08 |
| California Office of Environmental Health Hazard Assessment (OEHHA) (United States (California)) | Aloe vera, non-decolorized whole leaf extract is on the Proposition 65 list as a cancer-causing chemical; decolorized whole-leaf extract is not listed. source | 2020-11 (fact sheet) |
| NIH LiverTox (United States) | Aloe Vera entry: oral forms linked to rare instances of clinically apparent liver injury. source | 2022-05-24 |
| NIH LactMed (United States) | Aloe entry: gel is distinct from latex; latex should not be used during breastfeeding; gel on nipples should be washed off before feeding; gel can cause itching, burning and contact dermatitis, possibly from latex contamination. source | 2024-11-15 |
When to get medical help
- Swelling of the face, lips or throat, trouble breathing or widespread hives after aloe: call emergency services.
- Yellow skin or eyes, dark urine, pale stools, severe tiredness or pain in the upper right belly after taking oral aloe: stop and see a doctor the same day.
- Severe or bloody diarrhoea, severe belly pain, vomiting, marked weakness, muscle cramps or a fluttering or irregular heartbeat after a laxative aloe product (possible low potassium or dehydration): get urgent care.
- Blood in the urine or foamy urine, or very little urine, after long use of aloe laxatives: see a doctor.
- A rash, blistering or swelling where aloe was applied: wash it off, stop using it, and see a clinician if it does not settle.
- Skin that is red, hot, painful or oozing around a wound treated with aloe, or a burn that is large, deep, blistering over a large area or on the face, hands or genitals: seek medical care rather than self-treatment.
- Any laxative-type aloe in pregnancy or while breastfeeding, or given to a child under 12: stop and ask a doctor or pharmacist.
- Heavy bleeding during or after surgery in someone who took oral aloe: tell the team about the aloe.
Stop the supplement and contact a clinician or emergency service. In the US, Poison Control is 1-800-222-1222.
General information only, not medical advice. Ask a clinician or pharmacist before use, especially with medicines, in pregnancy or with a health condition. See the Natural Remedy Safety guide.
Frequently asked questions
Does aloe vera help burns?
Probably a little for minor first- and second-degree burns, with low certainty. Pooled analyses of small trials found healing about 4 days sooner than with other dressings, but the older Cochrane review found no clear gain over silver sulfadiazine and called the trials poor quality. Pain relief is not shown. It is not for serious burns, which need medical care.
What is the difference between aloe gel, aloe latex and whole-leaf extract?
The gel is the clear material in the centre of the leaf, used on skin and in drinks. The latex is the bitter yellow juice under the leaf skin, rich in aloin, and is a strong laxative. Whole-leaf extract comes from the whole leaf and can hold both; a decolorized extract has the anthraquinones filtered out, a non-decolorized one does not. Most of the serious warnings belong to the latex and the non-decolorized extract. Labels do not always make clear which you are buying.
Does aloe vera help psoriasis, acne or skin damage from radiotherapy?
The trials disagree for psoriasis: one reported a large effect, a placebo-controlled trial found the gel did slightly worse than placebo, and another found a cream similar to a steroid cream. For acne, one trial found aloe gel added to tretinoin cream reduced pimples more (low). Radiotherapy skin reactions were not prevented in the largest trials. Ask your skin or cancer team before using aloe on treated skin.
Does aloe vera help with sunburn?
Not in the one small trial we found: aloe vera cream gave no sunburn or tan protection and did no better than placebo for treating sunburn. Cooling and moisturising may be comforting, but sun protection is what prevents sunburn.
Does aloe vera lower blood sugar?
Pooled trials of oral aloe found lower fasting blood sugar and HbA1c in people with prediabetes or type 2 diabetes, but results varied a lot between reviews, products differed, and one review showed publication bias, so we rate it low. Aloe could add to diabetes medicines, so tell your doctor before using it.
Is aloe vera good for irritable bowel syndrome, ulcerative colitis or acid reflux?
The evidence is small. Three small irritable bowel trials (151 people) showed a modest benefit (low). One 44-person ulcerative colitis trial found more responders with oral aloe gel but not significantly more remissions (low). A pilot reflux trial had no placebo group (very low). NCCIH says there is not enough reliable information for irritable bowel syndrome and ulcerative colitis. Do not use aloe latex for these conditions.
Is aloe juice or aloe latex a safe laxative?
Aloe latex and aloin are strong stimulant laxatives. The EU accepts the dried juice only for short-term use in occasional constipation, in adults and adolescents over 12, and warns of cramps, diarrhoea, potassium loss and dependence with longer use. They must not be used in pregnancy, breastfeeding, under age 12, bowel obstruction or inflammatory bowel disease. The US FDA removed aloe from over-the-counter laxatives in 2002, according to NCCIH. Clear aloe gel does not act this way.
Can aloe vera cause cancer?
Not shown in people. In a two-year US National Toxicology Program study, a non-decolorized whole-leaf extract caused large-intestine cancers in rats, and IARC rates this extract possibly carcinogenic to humans (Group 2B), based on animal evidence. California lists it under Proposition 65. A decolorized extract has the anthraquinones filtered out and is not the material that was tested. Older human studies of anthranoid laxatives in general did not find a higher colorectal cancer risk, but they were not about aloe alone.
Can aloe vera damage the liver?
Oral aloe products have been linked to rare cases of liver injury. LiverTox calls it rare, and case reports describe hepatitis that cleared after stopping, in people who had taken aloe preparations for weeks to months. NCCIH says the time on aloe ranged from 3 weeks to 5 years. We do not know which product caused each case. Stop and see a doctor for yellow skin or eyes, dark urine or pale stools.
Is aloe vera safe in pregnancy and breastfeeding?
Avoid oral aloe. The EU contraindicates aloe dried juice in pregnancy and breastfeeding, NCCIH says oral aloe gel, latex or whole-leaf extract may be unsafe in both, and LactMed says latex should not be used while breastfeeding. If gel was put on the nipples, wash it off before feeding because the taste may upset the baby or cause diarrhoea.
What medicines does aloe vera interact with?
Aloe latex can add to potassium loss from water pills, steroids and liquorice, and low potassium can strengthen digoxin-type heart drugs and affect heart rhythm medicines (EU guidance). Oral aloe could add to diabetes medicines (theory; no study of the combination). One case report links oral aloe and the anaesthetic sevoflurane to heavy bleeding. Tell your doctor or pharmacist about any aloe product.
Can aloe vera on the skin cause allergy or side effects?
Yes, in some people. NCCIH reports occasional burning, itching, rash and eczema. A radiotherapy trial saw rare contact dermatitis, a psoriasis trial reported mostly dryness, and a case report describes allergic dermatitis to home-made leaf juice; a patch-test study of 702 people found no sensitization. Irritation may sometimes come from latex contamination. Stop use if you get a rash.
Explore by health goal
Healthy SkinDigestive SupportInflammation BalanceGut HealthMetabolic HealthBlood Sugar BalanceWeight ManagementCholesterol Balance
Editorial transparency
- Written by
- AlternativeMed editorial team. Research compiled with AI assistance, then checked against PubMed records.
- Medical review
- None. This page has not been reviewed by a physician or pharmacist.
- First published
- 2026-10-25
- Last substantive update
- 2026-10-25
- How we research
- We searched PubMed, read the EU herbal monograph on aloe dried leaf juice in full, the California Proposition 65 fact sheet, the abstracts of the NTP, LiverTox and LactMed records, and the US National Center for Complementary and Integrative Health page on aloe vera (through a page-summary tool), and checked plant names in GBIF and the NCBI taxonomy and compounds in PubChem. Only abstracts were read for nearly all studies. Some sources were not verified: the full LiverTox chapter, the IARC monograph and the FDA 2002 rule (known only through NCCIH and a review), the German Commission E monograph and the World Health Organization monographs. Certainty ratings are the compiler's own reading, not formal grades. No study is cited that we could not verify.
- How we rate evidence
- See "How we rate evidence" in the Evidence tab.
- Independence
- No product is promoted on this page. No affiliate links are shown. If one is added later it will be labelled and kept apart from the evidence.
Sources 65
Each source was opened and checked. Where we read only the abstract, it says so. The small numbers in the text point here.
- Al-Maweri SA, Ashraf S, Lingam AS et al.. Aloe vera in treatment of oral submucous fibrosis: A systematic review and meta-analysis.. J Oral Pathol Med. 2019. PMID 30329174. DOI 10.1111/jop.12789. (abstract)
- Al-Maweri SA, Nassani MZ, Alaizari N et al.. Efficacy of aloe vera mouthwash versus chlorhexidine on plaque and gingivitis: A systematic review.. Int J Dent Hyg. 2020. PMID 30829440. DOI 10.1111/idh.12393. (abstract)
- Ali S, Wahbi W. The efficacy of aloe vera in management of oral lichen planus: a systematic review and meta-analysis.. Oral Dis. 2017. PMID 28029732. DOI 10.1111/odi.12631. (abstract)
- Araya-Quintanilla F, Gutiérrez-Espinoza H, Cuyul-Vásquez I et al.. Effectiveness of aloe vera in patients with type 2 Diabetes Mellitus and pre-diabetes: An overview of systematic reviews.. Diabetes Metab Syndr. 2021. PMID 34563809. DOI 10.1016/j.dsx.2021.102292. (abstract)
- Benzie IFF, Wachtel-Galor S, Foster M et al.. Evaluation of the Nutritional and Metabolic Effects of Aloe vera.. . 2011. PMID 22593933. (abstract)
- Bottenberg MM, Wall GC, Harvey RL et al.. Oral aloe vera-induced hepatitis.. Ann Pharmacother. 2007. PMID 17726067. DOI 10.1345/aph.1K132. (abstract)
- Boudreau MD, Beland FA. An evaluation of the biological and toxicological properties of Aloe barbadensis (miller), Aloe vera.. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2006. PMID 16690538. DOI 10.1080/10590500600614303. (abstract)
- Boudreau MD, Beland FA, Nichols JA et al.. Toxicology and carcinogenesis studies of a nondecolorized [corrected] whole leaf extract of Aloe barbadensis Miller (Aloe vera) in F344/N rats and B6C3F1 mice (drinking water study).. Natl Toxicol Program Tech Rep Ser. 2013. PMID 24042237. (abstract)
- Burusapat C, Supawan M, Pruksapong C et al.. Topical Aloe Vera Gel for Accelerated Wound Healing of Split-Thickness Skin Graft Donor Sites: A Double-Blind, Randomized, Controlled Trial and Systematic Review.. Plast Reconstr Surg. 2018. PMID 29649056. DOI 10.1097/PRS.0000000000004515. (abstract)
- Choi HC, Kim SJ, Son KY et al.. Metabolic effects of aloe vera gel complex in obese prediabetes and early non-treated diabetic patients: randomized controlled trial.. Nutrition. 2013. PMID 23735317. DOI 10.1016/j.nut.2013.02.015. (abstract)
- Choonhakarn C, Busaracome P, Sripanidkulchai B et al.. A prospective, randomized clinical trial comparing topical aloe vera with 0.1% triamcinolone acetonide in mild to moderate plaque psoriasis.. J Eur Acad Dermatol Venereol. 2010. PMID 19686327. DOI 10.1111/j.1468-3083.2009.03377.x. (abstract)
- Cássia-Santos D, Santos CKC, Fernandes LT et al.. Effectiveness of Aloe vera in the treatment of oral mucositis: a systematic review and meta-analysis of randomized controlled trials.. Int J Oral Maxillofac Surg. 2025. PMID 39909775. DOI 10.1016/j.ijom.2025.01.015. (abstract)
- Dat AD, Poon F, Pham KB et al.. Aloe vera for treating acute and chronic wounds.. Cochrane Database Syst Rev. 2012. PMID 22336851. DOI 10.1002/14651858.CD008762.pub2. (abstract)
- Deora N, Venkatraman K. Aloe vera in diabetic dyslipidemia: Improving blood glucose and lipoprotein levels in pre-clinical and clinical studies.. J Ayurveda Integr Med. 2022. PMID 36481618. DOI 10.1016/j.jaim.2022.100675. (abstract)
- Dhingra K. Aloe vera herbal dentifrices for plaque and gingivitis control: a systematic review.. Oral Dis. 2014. PMID 23607360. DOI 10.1111/odi.12113. (abstract)
- Dick WR, Fletcher EA, Shah SA. Reduction of Fasting Blood Glucose and Hemoglobin A1c Using Oral Aloe Vera: A Meta-Analysis.. J Altern Complement Med. 2016. PMID 27152917. DOI 10.1089/acm.2015.0122. (abstract)
- Dong X, Zeng Y, Liu Y et al.. Aloe-emodin: A review of its pharmacology, toxicity, and pharmacokinetics.. Phytother Res. 2020. PMID 31680350. DOI 10.1002/ptr.6532. (abstract)
- Ferreira M, Teixeira M, Silva E et al.. Allergic contact dermatitis to Aloe vera.. Contact Dermatitis. 2007. PMID 17868225. DOI 10.1111/j.1600-0536.2007.01118.x. (abstract)
- Gok Metin Z, Helvaci A, Gulbahar Eren M. Effects of Aloe vera in adults with mucocutaneous problems: A systematic review and meta-analysis.. J Adv Nurs. 2021. PMID 33336470. DOI 10.1111/jan.14653. (abstract)
- Guo X, Mei N. Aloe vera: A review of toxicity and adverse clinical effects.. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2016. PMID 26986231. DOI 10.1080/10590501.2016.1166826. (abstract)
- Hajheydari Z, Saeedi M, Morteza-Semnani K et al.. Effect of Aloe vera topical gel combined with tretinoin in treatment of mild and moderate acne vulgaris: a randomized, double-blind, prospective trial.. J Dermatolog Treat. 2014. PMID 23336746. DOI 10.3109/09546634.2013.768328. (abstract)
- Hong SW, Chun J, Park S et al.. Aloe vera Is Effective and Safe in Short-term Treatment of Irritable Bowel Syndrome: A Systematic Review and Meta-analysis.. J Neurogastroenterol Motil. 2018. PMID 30153721. DOI 10.5056/jnm18077. (abstract)
- Huang YN, Chen KC, Wang JH et al.. Effects of Aloe vera on Burn Injuries: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.. J Burn Care Res. 2024. PMID 38605441. DOI 10.1093/jbcr/irae061. (abstract)
- Irani PS, Ranjbar H, Mehdipour-Rabori R et al.. The Effect of Aloe vera on the Healing of Diabetic Foot Ulcer: A Randomized, Double-blind Clinical Trial.. Curr Drug Discov Technol. 2024. PMID 37670716. DOI 10.2174/1570163820666230904150945. (abstract)
- Jangra A, Sharma G, Sihag S et al.. The dark side of miracle plant-Aloe vera: a review.. Mol Biol Rep. 2022. PMID 35092563. DOI 10.1007/s11033-022-07176-9. (abstract)
- Jettanacheawchankit S, Sasithanasate S, Sangvanich P et al.. Acemannan stimulates gingival fibroblast proliferation; expressions of keratinocyte growth factor-1, vascular endothelial growth factor, and type I collagen; and wound healing.. J Pharmacol Sci. 2009. PMID 19372635. DOI 10.1254/jphs.08204fp. (abstract)
- Kaparakou EH, Kanakis CD, Gerogianni M et al.. Quantitative determination of aloin, antioxidant activity, and toxicity of Aloe vera leaf gel products from Greece.. J Sci Food Agric. 2021. PMID 32643805. DOI 10.1002/jsfa.10650. (abstract)
- Kim ST, Pressman P, Clemens R et al.. The absence of genotoxicity of Aloe vera beverages: A review of the literature.. Food Chem Toxicol. 2023. PMID 36702364. DOI 10.1016/j.fct.2023.113628. (abstract)
- Kune GA. Laxative use not a risk for colorectal cancer: data from the Melbourne Colorectal Cancer Study.. Z Gastroenterol. 1993. PMID 8465555. (abstract)
- Lang W. Pharmacokinetic-metabolic studies with 14C-aloe emodin after oral administration to male and female rats.. Pharmacology. 1993. PMID 8234417. DOI 10.1159/000139849. (abstract)
- Langmead L, Feakins RM, Goldthorpe S et al.. Randomized, double-blind, placebo-controlled trial of oral aloe vera gel for active ulcerative colitis.. Aliment Pharmacol Ther. 2004. PMID 15043514. DOI 10.1111/j.1365-2036.2004.01902.x. (abstract)
- Lee A, Chui PT, Aun CS et al.. Possible interaction between sevoflurane and Aloe vera.. Ann Pharmacother. 2004. PMID 15292490. DOI 10.1345/aph.1E098. (abstract)
- Maenthaisong R, Chaiyakunapruk N, Niruntraporn S et al.. The efficacy of aloe vera used for burn wound healing: a systematic review.. Burns. 2007. PMID 17499928. DOI 10.1016/j.burns.2006.10.384. (abstract)
- Najafian Y, Khorasani ZM, Najafi MN et al.. Efficacy of Aloe vera/ Plantago Major Gel in Diabetic Foot Ulcer: A Randomized Double-Blind Clinical Trial.. Curr Drug Discov Technol. 2019. PMID 29336265. DOI 10.2174/1570163815666180115093007. (abstract)
- Nascimbeni R, Donato F, Ghirardi M et al.. Constipation, anthranoid laxatives, melanosis coli, and colon cancer: a risk assessment using aberrant crypt foci.. Cancer Epidemiol Biomarkers Prev. 2002. PMID 12163329. (abstract)
- National Institute of Child Health and Human Development (database entry; updated 2024-11-15). Aloe (LactMed entry). Drugs and Lactation Database (LactMed). 2024. PMID 30000889. (abstract)
- National Institute of Diabetes and Digestive and Kidney Diseases (database entry; updated 2022-05-24). Aloe Vera (LiverTox entry). LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. 2022. PMID 31643946. (abstract)
- Nusko G, Schneider B, Schneider I et al.. Anthranoid laxative use is not a risk factor for colorectal neoplasia: results of a prospective case control study.. Gut. 2000. PMID 10764708. DOI 10.1136/gut.46.5.651. (abstract)
- Odes HS, Madar Z. A double-blind trial of a celandin, aloevera and psyllium laxative preparation in adult patients with constipation.. Digestion. 1991. PMID 1800188. DOI 10.1159/000200705. (abstract)
- Panahi Y, Khedmat H, Valizadegan G et al.. Efficacy and safety of Aloe vera syrup for the treatment of gastroesophageal reflux disease: a pilot randomized positive-controlled trial.. J Tradit Chin Med. 2015. PMID 26742306. DOI 10.1016/s0254-6272(15)30151-5. (abstract)
- Paulsen E, Korsholm L, Brandrup F. A double-blind, placebo-controlled study of a commercial Aloe vera gel in the treatment of slight to moderate psoriasis vulgaris.. J Eur Acad Dermatol Venereol. 2005. PMID 15857459. DOI 10.1111/j.1468-3083.2004.01186.x. (abstract)
- Puvabanditsin P, Vongtongsri R. Efficacy of aloe vera cream in prevention and treatment of sunburn and suntan.. J Med Assoc Thai. 2005. PMID 16623024. (abstract)
- Radha MH, Laxmipriya NP. Evaluation of biological properties and clinical effectiveness of Aloe vera: A systematic review.. J Tradit Complement Med. 2015. PMID 26151005. DOI 10.1016/j.jtcme.2014.10.006. (abstract)
- Reddy RL, Reddy RS, Ramesh T et al.. Randomized trial of aloe vera gel vs triamcinolone acetonide ointment in the treatment of oral lichen planus.. Quintessence Int. 2012. PMID 23041995. (abstract)
- Reider N, Issa A, Hawranek T et al.. Absence of contact sensitization to Aloe vera (L.) Burm. f.. Contact Dermatitis. 2005. PMID 16364121. DOI 10.1111/j.0105-1873.2005.00713.x. (abstract)
- Richardson J, Smith JE, McIntyre M et al.. Aloe vera for preventing radiation-induced skin reactions: a systematic literature review.. Clin Oncol (R Coll Radiol). 2005. PMID 16149293. DOI 10.1016/j.clon.2005.04.013. (abstract)
- Sadgrove NJ, Simmonds MSJ. Pharmacodynamics of Aloe vera and acemannan in therapeutic applications for skin, digestion, and immunomodulation.. Phytother Res. 2021. PMID 34427371. DOI 10.1002/ptr.7242. (abstract)
- Sahebnasagh A, Saghafi F, Ghasemi A et al.. Aloe vera for Prevention of Acute Radiation Proctitis in Colorectal Cancer a Preliminary Randomized, Placebo-Controlled Clinical Trial.. J Gastrointest Cancer. 2022. PMID 33616843. DOI 10.1007/s12029-021-00597-y. (abstract)
- Sharma S, Alfonso AR, Gordon AJ et al.. Second-Degree Burns and Aloe Vera: A Meta-analysis and Systematic Review.. Adv Skin Wound Care. 2022. PMID 36264753. DOI 10.1097/01.ASW.0000875056.29059.78. (abstract)
- Suksomboon N, Poolsup N, Punthanitisarn S. Effect of Aloe vera on glycaemic control in prediabetes and type 2 diabetes: a systematic review and meta-analysis.. J Clin Pharm Ther. 2016. PMID 27009750. DOI 10.1111/jcpt.12382. (abstract)
- Syed TA, Ahmad SA, Holt AH et al.. Management of psoriasis with Aloe vera extract in a hydrophilic cream: a placebo-controlled, double-blind study.. Trop Med Int Health. 1996. PMID 8765459. DOI 10.1046/j.1365-3156.1996.d01-91.x. (abstract)
- Thunyakitpisal P, Ruangpornvisuti V, Kengkwasing P et al.. Acemannan increases NF-κB/DNA binding and IL-6/-8 expression by selectively binding Toll-like receptor-5 in human gingival fibroblasts.. Carbohydr Polym. 2017. PMID 28189222. DOI 10.1016/j.carbpol.2016.12.034. (abstract)
- Tungkasamit T, Chakrabandhu S, Samakgarn V et al.. Reduction in severity of radiation-induced dermatitis in head and neck cancer patients treated with topical aloe vera gel: A randomized multicenter double-blind placebo-controlled trial.. Eur J Oncol Nurs. 2022. PMID 35767935. DOI 10.1016/j.ejon.2022.102164. (abstract)
- Williams MS, Burk M, Loprinzi CL et al.. Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity.. Int J Radiat Oncol Biol Phys. 1996. PMID 8892458. DOI 10.1016/s0360-3016(96)00320-3. (abstract)
- Xie C, Jing Z, Xue M. CLINICAL EFFECT OF LOCAL ALOE VERA USE AS AN ADJUNCT TO PERIODONTAL THERAPY: A SYSTEMATIC REVIEW AND META-ANALYSIS.. J Evid Based Dent Pract. 2025. PMID 41290277. DOI 10.1016/j.jebdp.2025.102167. (abstract)
- Yang HN, Kim DJ, Kim YM et al.. Aloe-induced toxic hepatitis.. J Korean Med Sci. 2010. PMID 20191055. DOI 10.3346/jkms.2010.25.3.492. (abstract)
- Yun JM, Singh S, Jialal R et al.. A randomized placebo-controlled crossover trial of aloe vera on bioavailability of vitamins C and B(12), blood glucose, and lipid profile in healthy human subjects.. J Diet Suppl. 2010. PMID 22435613. DOI 10.3109/19390211003781693. (abstract)
- Zhang L, Tizard IR. Activation of a mouse macrophage cell line by acemannan: the major carbohydrate fraction from Aloe vera gel.. Immunopharmacology. 1996. PMID 8956975. DOI 10.1016/s0162-3109(96)00135-x. (abstract)
- . EMA/HMPC European Union herbal monograph on Aloe barbadensis Mill. and on Aloe (various species, mainly Aloe ferox Mill. and its hybrids), folii succus siccatus (EMA/HMPC/625788/2015, adopted 22 November 2016). . . (full-text)
- . US FDA 2002 final rule removing aloe and cascara sagrada from OTC laxative products (67 FR 31125). . . (summary-only)
- . GBIF Backbone Taxonomy: Aloe vera (L.) Burm.f. (usageKey 2777724). . . (full-text)
- . IARC Monographs vol. 108: Some Drugs and Herbal Products (2016), Aloe vera section, pp. 37-71. . . (summary-only)
- . NCBI Taxonomy: Aloe vera (taxid 34199). . . (full-text)
- . NCCIH: Aloe Vera - Usefulness and Safety (page last updated February 2025). . . (full-text)
- . OEHHA Proposition 65 Warnings fact sheet: Aloe Vera, Non-decolorized Whole Leaf Extract (November 2020). . . (full-text)
Where to buy
Check the label first. Whatever you buy, look for these:
- The plant part and the extract type or ratio on the label
- A standardized amount of the active compounds, where relevant
- A third-party testing mark (USP, NSF or ConsumerLab)
- Interactions: ask a pharmacist if you take medicines, are pregnant or have a medical condition
Talk to a pharmacist or doctor before you start any supplement, especially if you take medicines. See the Safety tab for interactions.
Support our free guides: as an Amazon Associate we earn from qualifying purchases. Full disclosure.